{"meta":{"query_hash":"d4c37e2a5671","filters":{"venue":"Cancer Investigation"},"cohort_total":50,"direct_labels_cover":0,"predictions_cover":50,"exported":50,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d4c37e2a5671","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Investigation"},"results":[{"id":"W1681690519","doi":"10.3109/07357900009032835","title":"Should Tamoxifen Be Used to Treat Premenopausal Women with Breast Cancer?","year":2000,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Oncology; Gynecology; Cancer; Antiestrogen; Internal medicine","score_opus":0.02092861951392712,"score_gpt":0.2693552913173837,"score_spread":0.24842667180345662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1681690519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964471,0.0005481845,0.000014543687,0.0019710846,0.00006365587,0.00032607038,0.000077265955,0.00003362832,0.0005184896],"genre_scores_gemma":[0.99486524,0.00020127556,0.00010807063,0.001649806,0.0003383656,0.00043475383,0.000092158145,0.00003666452,0.0022736397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990198,0.00004301686,0.00012681095,0.0003507557,0.00016613226,0.0002935042],"domain_scores_gemma":[0.99940944,0.0000041956564,0.000043265518,0.00022279659,0.000058244666,0.00026204315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072455,0.00017712243,0.00012834954,0.000031520787,0.00008698002,0.00002934121,0.00011794277,0.00014956474,0.0002506015],"category_scores_gemma":[0.000004652416,0.00014307858,0.00001921527,0.00018352708,0.00008863968,0.000010119946,0.000018494633,0.00009606855,0.000016655442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062495255,0.000028091912,0.012639083,0.00003241338,0.000091610986,0.000004204947,0.00078162324,0.0036990573,0.95599866,0.000013176958,0.005767191,0.02031993],"study_design_scores_gemma":[0.001775424,0.0012033286,0.03147908,0.0001263484,0.00009369437,0.000025110598,0.00006786371,0.000120859935,0.94097215,0.0000586851,0.023495266,0.0005822029],"about_ca_topic_score_codex":0.00030863425,"about_ca_topic_score_gemma":0.00012071733,"teacher_disagreement_score":0.019737728,"about_ca_system_score_codex":0.000117531265,"about_ca_system_score_gemma":0.00021028356,"threshold_uncertainty_score":0.58345747},"labels":[],"label_agreement":null},{"id":"W1787613411","doi":"10.3109/07357907.2015.1060996","title":"Claudin 1 Promotes Migration and Increases Sensitivity to Tamoxifen and Anticancer Drugs in Luminal-like Human Breast Cancer Cells MCF7","year":2015,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Downregulation and upregulation; Breast cancer; Claudin; Tamoxifen; Cancer research; Etoposide; Cancer; Medicine; Cisplatin; Oncology; Internal medicine; Tight junction; Chemistry; Biology; Chemotherapy; Cell biology","score_opus":0.04357083030038854,"score_gpt":0.2891912493118925,"score_spread":0.24562041901150394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1787613411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956865,0.00027947652,0.000020312125,0.0030689766,0.00034914742,0.00035783314,0.00009995667,0.00004782493,0.00009001331],"genre_scores_gemma":[0.99706453,0.0001396724,0.000071188435,0.0021890004,0.00028008298,0.00012504864,0.000004445802,0.000015521244,0.00011050945],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998647,0.00016005512,0.00021034465,0.0004958817,0.00025070153,0.00023606021],"domain_scores_gemma":[0.99933016,0.000079351485,0.00010533951,0.00013001745,0.0001078817,0.00024722092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026603314,0.00018299298,0.0002161724,0.00012890105,0.00019298011,0.00008024427,0.00004498533,0.000069172165,0.000011819208],"category_scores_gemma":[0.000119710996,0.00016938042,0.000015133776,0.00039444905,0.00033393144,0.0003789998,0.000080102545,0.00012719251,0.000002993029],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006629089,0.000016310234,0.25764668,0.000057019388,0.000007815034,0.0000043546465,0.0062661967,0.00009269083,0.7290109,0.00017884468,0.0035038984,0.003148987],"study_design_scores_gemma":[0.0007123414,0.0000773587,0.6144051,0.00016465705,0.000044090346,0.000022149048,0.00043821326,0.0006601419,0.38072425,0.001526611,0.0008685236,0.00035657268],"about_ca_topic_score_codex":0.009040051,"about_ca_topic_score_gemma":0.007220099,"teacher_disagreement_score":0.35675842,"about_ca_system_score_codex":0.0001398538,"about_ca_system_score_gemma":0.00012254555,"threshold_uncertainty_score":0.99755883},"labels":[],"label_agreement":null},{"id":"W1972192442","doi":"10.1081/cnv-200050453","title":"Benefit of Temozolomide Compared to Procarbazine in Treatment of Glioblastoma Multiforme at First Relapse: Effect on Neurological Functioning, Performance Status, and Health Related Quality of Life","year":2005,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Procarbazine; Temozolomide; Glioblastoma; Medicine; Quality of life (healthcare); Oncology; Karnofsky Performance Status; Health related quality of life; Internal medicine; Overall survival; Chemotherapy; Vincristine; Cancer research; Disease","score_opus":0.05254147227967874,"score_gpt":0.3164567422638571,"score_spread":0.26391526998417836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972192442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560016,0.001064348,3.8586924e-7,0.0022174222,0.000043214197,0.0010082835,0.000026387277,0.000016904594,0.000022868968],"genre_scores_gemma":[0.9990625,0.00030916536,0.00017435983,0.00018134237,0.000019130945,0.00017794312,0.000045276272,0.000010289664,0.00002002569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986458,0.000058928956,0.00067281286,0.0002496183,0.00020017002,0.00017268959],"domain_scores_gemma":[0.9990333,0.00012732363,0.00039290584,0.0001775948,0.00006999095,0.00019893328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002100362,0.00015046942,0.0005805866,0.00015102477,0.000043900618,0.0000020543487,0.000023804181,0.00006932049,0.000018593772],"category_scores_gemma":[0.00009993671,0.00011269112,0.000046844594,0.00028181844,0.000096228774,0.00004856319,0.000015372461,0.00005739194,0.0000025106795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021677213,0.00036619388,0.97780406,0.0003417015,0.000051428928,7.8510357e-7,0.00093296054,0.008755461,0.0025895233,0.00004217449,0.000075111544,0.006872892],"study_design_scores_gemma":[0.005616233,0.009687595,0.93420696,0.00039180453,0.0000374497,0.0000022031907,0.000012667599,0.00252721,0.04732928,0.000006106513,0.00011737092,0.00006513995],"about_ca_topic_score_codex":0.001439399,"about_ca_topic_score_gemma":0.0025738543,"teacher_disagreement_score":0.044739757,"about_ca_system_score_codex":0.00047542327,"about_ca_system_score_gemma":0.00009851176,"threshold_uncertainty_score":0.45954108},"labels":[],"label_agreement":null},{"id":"W1974941133","doi":"10.3109/07357907.2013.820319","title":"The Use of Salivary Protein Secretions as an<i>In Vivo</i>Model to Study Mantel Cell Lymphoma Progression and Treatment","year":2013,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institute for Theoretical Astrophysics","keywords":"In vivo; Saliva; Salivary Proteins; Chemotherapy; Lymphoma; Medicine; Salivary gland; Oncology; Internal medicine; Cancer research; Pathology; Immunology; Biology","score_opus":0.06818538827177109,"score_gpt":0.31944437943282394,"score_spread":0.2512589911610529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974941133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944237,0.0002906363,0.0000070436263,0.0014814468,0.000027310367,0.0036569068,0.000012744355,0.000021818281,0.00007837858],"genre_scores_gemma":[0.993642,0.00011690211,0.0016920025,0.0002693971,0.000027261538,0.0038550373,0.000013555185,0.000015550895,0.00036833528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991025,0.00006925158,0.00023787956,0.00025245413,0.00019010488,0.0001478503],"domain_scores_gemma":[0.9993236,0.00004313994,0.00008682312,0.00026871785,0.00009144746,0.00018627636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006793186,0.00013975153,0.00017128147,0.00006390386,0.00010675336,0.000044885495,0.00003890297,0.000044300014,0.000022564313],"category_scores_gemma":[0.000023770493,0.00008471452,0.000026053835,0.00014892388,0.00007221659,0.00017554585,0.000024424862,0.00002186371,0.000007339653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003762208,0.005041679,0.74889255,0.000085740394,0.00013786895,0.000026995558,0.009926631,0.00049158884,0.078352876,0.0005795096,0.0010088136,0.15507953],"study_design_scores_gemma":[0.008347512,0.0042153075,0.67933416,0.00051879225,0.0002200419,0.000008385728,0.00092705316,0.014177206,0.29017726,0.0009972397,0.00084191066,0.00023515424],"about_ca_topic_score_codex":0.0029679318,"about_ca_topic_score_gemma":0.00034960223,"teacher_disagreement_score":0.21182439,"about_ca_system_score_codex":0.00030003313,"about_ca_system_score_gemma":0.00021115801,"threshold_uncertainty_score":0.4486645},"labels":[],"label_agreement":null},{"id":"W1986130879","doi":"10.3109/07357907.2014.919306","title":"Changes in PKM2 Associate with Prostate Cancer Progression","year":2014,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"PKM2; Prostate cancer; Cancer research; Anaerobic glycolysis; Pyruvate kinase; Cancer; Medicine; Warburg effect; Prostate; Cancer stem cell; Glycolysis; Cancer cell; Oncology; Internal medicine; Metabolism","score_opus":0.012877886601504808,"score_gpt":0.27287641856354394,"score_spread":0.25999853196203915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986130879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370575,0.0035362586,0.00003955441,0.0014281445,0.0006660974,0.00032379632,0.000022710701,0.00001957256,0.0002581117],"genre_scores_gemma":[0.9926151,0.0018700758,0.00030114045,0.0012929544,0.0019975007,0.0007170369,0.00012466635,0.00003410644,0.0010474232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909705,0.0000659209,0.00012524852,0.00031886718,0.00015098932,0.00024191722],"domain_scores_gemma":[0.9995103,0.0000047920357,0.00013428935,0.00016701527,0.00009415666,0.00008943769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018879895,0.00013950774,0.00014176844,0.00004754448,0.000056240828,0.000023949386,0.000086923304,0.00010902478,0.000014765092],"category_scores_gemma":[0.000036981844,0.000117036296,0.00002152857,0.0001593278,0.00009770925,0.000008508442,0.000029465207,0.00008860475,0.0000020373848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020813794,0.000025741845,0.11211437,0.000089649926,0.00003841664,3.9305223e-7,0.00063929486,0.00058862136,0.75891036,0.00009877366,0.0051819305,0.12210433],"study_design_scores_gemma":[0.0014738132,0.00020501851,0.084275074,0.00026884896,0.00003662516,0.000001137923,0.000047322075,0.00024563365,0.67683375,0.00030082103,0.23596813,0.00034380244],"about_ca_topic_score_codex":0.00033920037,"about_ca_topic_score_gemma":0.0078162085,"teacher_disagreement_score":0.23078619,"about_ca_system_score_codex":0.000054700555,"about_ca_system_score_gemma":0.00019053875,"threshold_uncertainty_score":0.47726017},"labels":[],"label_agreement":null},{"id":"W1986576258","doi":"10.3109/07357900903095672","title":"Recombinant Human Interleukin-24 Suppresses Gastric Carcinoma Cell Growth<i>In Vitro</i>and<i>In Vivo</i>","year":2009,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"In vivo; Cancer research; Angiogenesis; Biology; Cancer; In vitro; Molecular biology; Cancer cell; Biochemistry","score_opus":0.020374268392780448,"score_gpt":0.2768438347979642,"score_spread":0.25646956640518376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986576258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968707,0.0018044034,0.000008843669,0.0006051688,0.00011193731,0.00025257914,0.000013243636,0.000010305561,0.0003228337],"genre_scores_gemma":[0.99815685,0.0003594258,0.00010462195,0.00075760146,0.00011526105,0.0000698383,0.00007034941,0.000020062347,0.00034597114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987596,0.00011933029,0.0002486469,0.0004135596,0.00013628318,0.00032256378],"domain_scores_gemma":[0.9995315,0.00001025632,0.000068490306,0.00022033454,0.000058721052,0.00011067941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020731411,0.00016668376,0.00015696195,0.00015819377,0.000052173167,0.000031677562,0.0001846151,0.00011761928,0.000022305376],"category_scores_gemma":[0.00002483188,0.00017524563,0.00003747214,0.00025109926,0.000099335186,0.000012470326,0.000042008727,0.00016557766,0.0000025832176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039027262,0.000042300864,0.019362092,0.000029215622,0.0000033073393,0.000005650895,0.00011932766,0.000049473532,0.9778915,0.00001167254,0.001112978,0.0009821879],"study_design_scores_gemma":[0.0010675791,0.0007705856,0.01577549,0.00003344154,0.0000049333416,0.0000032862683,0.00003108028,0.00008646263,0.9808767,0.0006980721,0.00047115982,0.00018123361],"about_ca_topic_score_codex":0.00025781765,"about_ca_topic_score_gemma":0.00061183365,"teacher_disagreement_score":0.0035866005,"about_ca_system_score_codex":0.00008716118,"about_ca_system_score_gemma":0.00013512404,"threshold_uncertainty_score":0.71463096},"labels":[],"label_agreement":null},{"id":"W1998582467","doi":"10.1080/07357900601063790","title":"Clinical Activity of Celecoxib in Metastatic Malignant Melanoma","year":2006,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Celecoxib; Melanoma; Metastatic melanoma; Internal medicine; Metastasis; Disease; Oncology; Stage (stratigraphy); Progressive disease; Cancer; Gastroenterology; Surgery; Cancer research","score_opus":0.04155444907087426,"score_gpt":0.33558109085562865,"score_spread":0.2940266417847544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998582467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843764,0.00023560216,0.000052734777,0.00027935018,0.00026210555,0.0003197322,0.0000056908452,0.000017647571,0.0003894724],"genre_scores_gemma":[0.9988165,0.00002434549,0.0005733291,0.00014873267,0.00023771261,0.000052949457,0.0000122323345,0.000011347765,0.00012288199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990575,0.00011576751,0.0003580402,0.00016386733,0.00016571711,0.00013914783],"domain_scores_gemma":[0.9994436,0.00011663129,0.00016479004,0.00014111727,0.00005674544,0.000077100034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049283606,0.00008699845,0.00029383803,0.0000903348,0.000014739704,0.0000031667573,0.00003379358,0.0000642283,0.00005374603],"category_scores_gemma":[0.00012479234,0.000074464246,0.00005982704,0.00019645924,0.00011817463,0.00007129581,0.000008984676,0.00013136335,0.000008439483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011305703,0.00009141768,0.9190908,0.00028558637,0.000019797115,0.000029752524,0.00008623553,0.000074715485,0.07099199,0.0003824659,0.0010461779,0.007787984],"study_design_scores_gemma":[0.0012724149,0.00013037173,0.80045193,0.00018097107,0.00005526602,0.0000034127645,0.000007095329,0.0013898262,0.19526115,0.0008503478,0.00032417913,0.00007300697],"about_ca_topic_score_codex":0.0007587791,"about_ca_topic_score_gemma":0.00033917898,"teacher_disagreement_score":0.12426916,"about_ca_system_score_codex":0.0000836237,"about_ca_system_score_gemma":0.0002737342,"threshold_uncertainty_score":0.3036564},"labels":[],"label_agreement":null},{"id":"W2002650137","doi":"10.1080/07357900600629575","title":"Rat PSP94 Inhibits the Growth and Viability of the Rat Adenocarcinoma Cell Line PAIII In Vitro","year":2006,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Lawson Health Research Institute; Western University","funders":"","keywords":"In vitro; Apoptosis; Cell culture; Biology; In vivo; Programmed cell death; Annexin; Cell growth; TUNEL assay; Adenocarcinoma; Cell biology; Viability assay; Cancer research; Molecular biology; Cancer; Biochemistry; Genetics","score_opus":0.010358066752972562,"score_gpt":0.2146727353138076,"score_spread":0.20431466856083502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002650137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967443,0.0018728046,0.000027700631,0.0008991316,0.00012925128,0.00018523606,0.00001120847,0.0000024714907,0.0001279234],"genre_scores_gemma":[0.99904096,0.00007921152,0.000030801864,0.00050460134,0.00013596835,0.00003062592,0.000031644417,0.000005982128,0.00014022908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999391,0.000083190636,0.00017335989,0.00018266795,0.00007287895,0.00009689913],"domain_scores_gemma":[0.99962884,0.000012273532,0.00008437522,0.00019366025,0.000060224083,0.000020609146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012307428,0.000082759776,0.00007693585,0.000014983585,0.00004526856,0.000010886735,0.00011487249,0.00007333693,0.00000291313],"category_scores_gemma":[0.000032884116,0.000052670865,0.000033724926,0.00010174851,0.000207078,0.000005614186,0.00006046612,0.00007302459,5.1028223e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029798508,0.000009718299,0.072665855,0.000025364872,0.0000022728927,9.983155e-8,0.00007921144,0.00010067567,0.9263043,0.000017202381,0.00060017756,0.00016532009],"study_design_scores_gemma":[0.00022413355,0.000040160565,0.046488155,0.000015307185,0.000007476498,8.423229e-7,0.0000425241,0.00013300414,0.95213246,0.0007065822,0.00014876401,0.000060610975],"about_ca_topic_score_codex":0.00046364358,"about_ca_topic_score_gemma":0.00029934538,"teacher_disagreement_score":0.0261777,"about_ca_system_score_codex":0.000013616534,"about_ca_system_score_gemma":0.00008159302,"threshold_uncertainty_score":0.21478556},"labels":[],"label_agreement":null},{"id":"W2005398645","doi":"10.1080/07357900600814839","title":"A Sequential Scanning of the Immune Efficiency in Astrocytoma (Grade I to Grade III), Meningioma and Secondary Glioma Patients with and without Therapeutic Scheduling","year":2006,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Astrocytoma; Meningioma; Glioma; Medicine; Immune system; Oncology; Internal medicine; Surgery; Cancer research; Immunology","score_opus":0.01712194722769551,"score_gpt":0.26227622961268676,"score_spread":0.24515428238499126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005398645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688876,0.0014958162,0.000028478806,0.0007517759,0.000051396462,0.0007399865,0.0000064487476,0.0000138668765,0.00002350275],"genre_scores_gemma":[0.9988103,0.0000034836005,0.000889665,0.00011525015,0.00003035397,0.00012106495,0.000010989674,0.000013690985,0.0000052369537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913454,0.0000338807,0.00023360258,0.00022274985,0.0002129263,0.0001623039],"domain_scores_gemma":[0.9995987,0.000017524868,0.00012804914,0.00012876309,0.000056963872,0.00007002784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079663856,0.00013389967,0.00020724189,0.00013885135,0.00008416112,0.000021903234,0.000040419087,0.0000416904,0.000003716356],"category_scores_gemma":[0.00000969043,0.00008262378,0.000023608713,0.0003829179,0.00015749551,0.00007943627,0.000029867626,0.000086985805,1.7912734e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010791049,0.00007990286,0.92764395,0.000050350463,0.00003670153,0.0000033578149,0.00070129265,0.00041583352,0.06880209,0.00014107928,0.0000038990443,0.0020136011],"study_design_scores_gemma":[0.0036698466,0.00024676995,0.8061482,0.000486438,0.00009112692,0.000012448206,0.00007470963,0.00053051545,0.18853259,0.00011793133,0.000010907289,0.00007854034],"about_ca_topic_score_codex":0.00064354093,"about_ca_topic_score_gemma":0.00016624175,"teacher_disagreement_score":0.12149581,"about_ca_system_score_codex":0.000098609016,"about_ca_system_score_gemma":0.000104353094,"threshold_uncertainty_score":0.33693},"labels":[],"label_agreement":null},{"id":"W2007519119","doi":"10.1080/07357900701208683","title":"Telomere Biology of Pediatric Cancer","year":2007,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Telomerase; Telomere; Telomerase reverse transcriptase; Cancer; Biology; Cancer research; Pediatric cancer; Mechanism (biology); Genetics; DNA; Gene","score_opus":0.20062530421029603,"score_gpt":0.44177627668692215,"score_spread":0.24115097247662612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007519119","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018937336,0.99533814,0.000020257656,0.00009683398,0.0010878221,0.00089124806,0.00019437907,0.00007850878,0.0003991032],"genre_scores_gemma":[0.00021888757,0.9956647,0.00031709045,0.0002889326,0.002296182,0.00025278016,0.00031808883,0.00007610834,0.00056719506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976164,0.000102272796,0.0010094907,0.0005716104,0.00029305526,0.00040714897],"domain_scores_gemma":[0.9979586,0.00015639797,0.0008469866,0.0004646569,0.0002788734,0.0002944894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027719897,0.0004547786,0.0018265139,0.00064091966,0.000058512993,0.000008823473,0.00021759966,0.0006344633,0.00036305],"category_scores_gemma":[0.00014989729,0.0003690906,0.0003507489,0.0013402893,0.00031496267,0.000072868585,0.000045644683,0.0005272136,0.000041136245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011244002,0.000025030218,0.006625603,0.028553601,0.00014990398,0.00000764541,0.00011000696,8.7737277e-7,0.00003812665,0.00026816127,0.00252568,0.9616841],"study_design_scores_gemma":[0.00035558606,0.000089376874,0.00076358876,0.00827306,0.002296315,0.000018792969,0.000012913802,0.0000041245016,0.00025442473,0.000121431156,0.9874095,0.0004008892],"about_ca_topic_score_codex":0.0006527001,"about_ca_topic_score_gemma":0.00006987215,"teacher_disagreement_score":0.98488384,"about_ca_system_score_codex":0.0003785011,"about_ca_system_score_gemma":0.002334258,"threshold_uncertainty_score":0.9998761},"labels":[],"label_agreement":null},{"id":"W2012331446","doi":"10.3109/07357900009012213","title":"Greater Expectations in a Cancer Trial: Absolute More Than Relative Survival Increases, Community More Than Academic Clinicians","year":2000,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Absolute (philosophy); Cancer; Medicine; Relative survival; Oncology; Internal medicine; Cancer registry","score_opus":0.5209175464903644,"score_gpt":0.4872048355757998,"score_spread":0.03371271091456457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012331446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579633,0.0023026157,0.00006694433,0.03532919,0.00067627936,0.001412608,0.00090161257,0.000102145015,0.0012453452],"genre_scores_gemma":[0.98597926,0.0007862853,0.00031433208,0.008459086,0.00077367935,0.0016677341,0.0002962272,0.000070686714,0.0016527105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937832,0.0013167018,0.003603786,0.0006119504,0.0001680079,0.0005163711],"domain_scores_gemma":[0.9962678,0.0010220116,0.001684265,0.0006403037,0.0000960598,0.00028956484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0069881217,0.0003180289,0.0009935678,0.00040991858,0.00042951968,0.000065745015,0.00043003162,0.0003905852,0.00089203747],"category_scores_gemma":[0.001600129,0.000403814,0.00015159449,0.00060623774,0.00033807885,0.0011356862,0.000045656016,0.0009899064,0.00045562326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009918676,0.00020400556,0.88831687,0.0002925777,0.00022099729,0.0000023508326,0.08263652,0.004482735,0.000009530771,0.009980868,0.011913606,0.000948052],"study_design_scores_gemma":[0.013905851,0.00017551273,0.9277544,0.0007388979,0.000052056617,0.0000022285085,0.010787965,0.010119184,0.000031184576,0.029097935,0.006395527,0.0009392612],"about_ca_topic_score_codex":0.081769235,"about_ca_topic_score_gemma":0.016381621,"teacher_disagreement_score":0.07184856,"about_ca_system_score_codex":0.0016190134,"about_ca_system_score_gemma":0.00057252333,"threshold_uncertainty_score":0.9998414},"labels":[],"label_agreement":null},{"id":"W2017601541","doi":"10.1080/07357900701518388","title":"Adjuvant Therapy with Raltitrexed in Patients with Colorectal Cancer Intolerant of 5-Fluorouracil: British Columbia Cancer Agency Experience","year":2007,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Raltitrexed; Medicine; Colorectal cancer; Cancer; Fluorouracil; Adjuvant; Oncology; Internal medicine; Adjuvant therapy; Oxaliplatin","score_opus":0.017782034611391728,"score_gpt":0.2747893821367695,"score_spread":0.2570073475253778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017601541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934821,0.00461424,0.000008077373,0.00014621842,0.0001892276,0.0012068142,0.000078742174,0.000037206635,0.00023736907],"genre_scores_gemma":[0.9968453,0.0013748448,0.00020886575,0.00032378704,0.00008393707,0.0008753317,0.000038086055,0.000033788725,0.00021608075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983451,0.000026875938,0.00038905806,0.0004128197,0.00047094063,0.00035520914],"domain_scores_gemma":[0.9990052,0.000029201065,0.00024854008,0.00014580594,0.00041917097,0.00015207805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100581805,0.00019787703,0.0004830403,0.00006975219,0.0001140831,0.000035432124,0.00007874188,0.00007602575,0.0003819007],"category_scores_gemma":[0.000016200367,0.00018599682,0.000040162755,0.0005881901,0.00035994707,0.00019951792,0.000020079453,0.00015287795,5.2256877e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016783014,0.00017395016,0.90311706,0.00006221865,0.0001291731,0.00002162713,0.0050091576,0.000050785704,0.0010543809,0.000001440622,0.00020856086,0.08849335],"study_design_scores_gemma":[0.006247809,0.0012686856,0.9834037,0.000978763,0.00006956838,0.0000030020524,0.00031068744,0.00003301707,0.007214564,0.000017659311,0.0002210357,0.00023154779],"about_ca_topic_score_codex":0.13510269,"about_ca_topic_score_gemma":0.410343,"teacher_disagreement_score":0.2752403,"about_ca_system_score_codex":0.0006799011,"about_ca_system_score_gemma":0.0005266326,"threshold_uncertainty_score":0.8706567},"labels":[],"label_agreement":null},{"id":"W2021704241","doi":"10.3109/07357907.2010.483508","title":"Disease Progression Increases the Risk of Skeletal-Related Events in Patients With Bone Metastases From Castration-Resistant Prostate Cancer, Lung Cancer, or Other Solid Tumors","year":2010,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Bone health and treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Zoledronic acid; Prostate cancer; Oncology; Cancer; Internal medicine; Lung cancer; Disease; Prostate","score_opus":0.012631920879963617,"score_gpt":0.3072983779499667,"score_spread":0.29466645707000305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021704241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926747,0.0025881596,0.0000010796415,0.0006491837,0.00019363411,0.0021777945,0.001674836,0.000034073775,0.0000065416452],"genre_scores_gemma":[0.9973654,0.00026278856,0.00019473227,0.00023223202,0.000054952314,0.0012510245,0.0004960842,0.00004049989,0.00010226738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981769,0.00015004852,0.00054563297,0.0003597331,0.00047704123,0.00029067497],"domain_scores_gemma":[0.9984032,0.00007854135,0.00062213547,0.00031547144,0.00022650765,0.00035417118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016255022,0.0002461811,0.0003709384,0.000099853176,0.00015417833,0.00001144381,0.00007281053,0.00007174799,0.00020350098],"category_scores_gemma":[0.00014086129,0.00013770588,0.000050075316,0.00040892823,0.00022743743,0.00020088187,0.00001925667,0.0002933731,0.0000016237394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027644776,0.000302173,0.9894262,0.00020047101,0.00018965393,0.000009876658,0.00038938428,0.00016008673,0.0007592474,0.000008900422,0.00012204537,0.0056675053],"study_design_scores_gemma":[0.0057545495,0.00022937951,0.9880125,0.00171881,0.00067953195,5.2521335e-7,0.000033585624,0.0007213073,0.0024846608,0.00015232131,0.00006210215,0.00015072545],"about_ca_topic_score_codex":0.057035897,"about_ca_topic_score_gemma":0.028088383,"teacher_disagreement_score":0.028947514,"about_ca_system_score_codex":0.00020980844,"about_ca_system_score_gemma":0.0016065583,"threshold_uncertainty_score":0.9896465},"labels":[],"label_agreement":null},{"id":"W2028160062","doi":"10.1081/cnv-120027590","title":"The Role of Surrogate Markers in the Clinical Development of Antiretroviral Therapy: A Model for Early Evaluation of Targeted Cancer Drugs","year":2004,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; St. Paul's Hospital; University of British Columbia; McGill University; McGill University Health Centre","funders":"","keywords":"Surrogate endpoint; Medicine; Clinical trial; Drug resistance; Efficacy; Drug development; Drug; Targeted therapy; Oncology; Cancer; Immunology; Internal medicine; Pharmacology; Biology","score_opus":0.15887438748470356,"score_gpt":0.4261522573596967,"score_spread":0.26727786987499313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028160062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08872802,0.90695566,0.000023401844,0.0001643963,0.00013425051,0.0038619551,0.00006758505,0.0000073245733,0.000057440957],"genre_scores_gemma":[0.05458811,0.94043124,0.0017671825,0.000028734274,0.00006078717,0.0025864353,0.00030361087,0.000040569787,0.00019333095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689585,0.00035537555,0.0014886907,0.0002891799,0.0007681529,0.00020273597],"domain_scores_gemma":[0.9976921,0.0002908063,0.0011669844,0.00029248864,0.0005041756,0.00005345582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031621896,0.00026968514,0.0010252417,0.00014963106,0.00007087213,0.0000082723855,0.00020762236,0.00019793889,0.000009244575],"category_scores_gemma":[0.00015185765,0.00015018541,0.0003043343,0.0004416302,0.00025024512,0.000059445912,0.000020138948,0.00019441341,7.0763997e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014766841,0.00008753719,0.004494452,0.002593574,0.00055927987,1.2580365e-7,0.005545872,0.00011404057,0.000012508491,0.0000884008,0.00007006577,0.98628646],"study_design_scores_gemma":[0.0626881,0.0025579836,0.0619411,0.26042297,0.029978782,0.0000082180995,0.005550791,0.08773528,0.013431335,0.018462865,0.4534349,0.0037876477],"about_ca_topic_score_codex":0.00015630694,"about_ca_topic_score_gemma":0.00014222671,"teacher_disagreement_score":0.9824988,"about_ca_system_score_codex":0.0005795651,"about_ca_system_score_gemma":0.008850048,"threshold_uncertainty_score":0.99676883},"labels":[],"label_agreement":null},{"id":"W2031379570","doi":"10.1081/cnv-67172","title":"State of the Art in Therapy for Non-Small Cell Lung Cancer","year":2005,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Disease; Chemotherapy; Radiation therapy; Intensive care medicine; Quality of life (healthcare); Oncology; Cancer; Adjuvant chemotherapy; Internal medicine; Surgery; Breast cancer; Nursing","score_opus":0.058486521006174144,"score_gpt":0.3933712949867484,"score_spread":0.33488477398057426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031379570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001486857,0.99255824,0.00003670676,0.00044793996,0.0004508198,0.004321335,0.00031594548,0.000013248996,0.00036890805],"genre_scores_gemma":[0.00012563662,0.9897543,0.00028260544,0.00044721534,0.0002970864,0.004233782,0.00020222427,0.000056763092,0.004600347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881494,0.00004323152,0.0004990827,0.0002924902,0.00015296976,0.00019731508],"domain_scores_gemma":[0.99897647,0.00006455021,0.00046061963,0.00029660316,0.00012638152,0.000075389835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104527666,0.00025634692,0.000750536,0.000120015844,0.000047529516,0.000011275691,0.000121996425,0.000120845165,0.000048326136],"category_scores_gemma":[0.000010111015,0.00016041886,0.00026700005,0.00037303258,0.000076832,0.000052528565,0.0000115160665,0.00018570607,0.0000027110066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015173685,0.000054789172,0.001366726,0.010270826,0.00022959572,6.6705877e-7,0.0007618857,0.00016129551,0.000019305007,0.0000129848895,0.005703991,0.98140275],"study_design_scores_gemma":[0.0015279093,0.000053167736,0.0008247187,0.01574207,0.0013489821,0.0000013812642,0.0000076480455,0.00015555532,0.00034456878,0.00006800163,0.9797504,0.00017558462],"about_ca_topic_score_codex":0.00030576927,"about_ca_topic_score_gemma":0.0005838026,"teacher_disagreement_score":0.98122716,"about_ca_system_score_codex":0.00075945136,"about_ca_system_score_gemma":0.0025953741,"threshold_uncertainty_score":0.65416914},"labels":[],"label_agreement":null},{"id":"W2036049436","doi":"10.1081/cnv-100000076","title":"The Role of Genetic Factors in the Etiology of Pancreatic Adenocarcinoma: An Update","year":2001,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal; Montreal General Hospital; McGill University","funders":"","keywords":"Etiology; Adenocarcinoma; Medicine; Oncology; Cancer research; Internal medicine; Bioinformatics; Biology; Cancer","score_opus":0.10782959290599846,"score_gpt":0.4004338703383076,"score_spread":0.2926042774323091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036049436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13436662,0.86398715,0.0000039974743,0.00011673033,0.000053598025,0.0010382546,0.000020730535,0.000005617425,0.00040732423],"genre_scores_gemma":[0.02257825,0.9765522,0.00010881752,0.00005362001,0.00012780525,0.0003493342,0.00013532134,0.000021498528,0.000073158764],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99761826,0.0008257668,0.00078060693,0.00024106838,0.0002807422,0.0002535356],"domain_scores_gemma":[0.99805826,0.00068571867,0.0005015164,0.0005503703,0.00011869124,0.00008543205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006818931,0.00020697358,0.0012985091,0.00015279117,0.000066846114,0.000006706586,0.00034401318,0.00028405362,0.000059001173],"category_scores_gemma":[0.00027669474,0.00010373723,0.00014159818,0.00051839434,0.00073420245,0.000032082226,0.0000311445,0.00040972023,0.0000050635344],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039641847,0.0000717866,0.6592132,0.005128236,0.0002799851,0.000009516248,0.0013776699,0.0000034037023,0.000023516923,0.0013036734,0.0001799114,0.33236945],"study_design_scores_gemma":[0.0011238018,0.0011295604,0.46856296,0.0104687195,0.005780777,0.0001325907,0.0017566772,0.00037088818,0.0000692108,0.006381977,0.50384116,0.0003816565],"about_ca_topic_score_codex":0.0008497886,"about_ca_topic_score_gemma":0.00023631705,"teacher_disagreement_score":0.5036613,"about_ca_system_score_codex":0.0001528844,"about_ca_system_score_gemma":0.0013025871,"threshold_uncertainty_score":0.42302814},"labels":[],"label_agreement":null},{"id":"W2037050175","doi":"10.1080/07357900802574660","title":"Pharmacology and Pharmacogenetics of Chemotherapeutic Agents","year":2009,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pharmacogenetics; Personalized medicine; Chemotherapeutic drugs; Medicine; Drug; Pharmacology; Precision medicine; Clinical pharmacology; Drug response; Intensive care medicine; Chemotherapy; Bioinformatics; Internal medicine; Biology; Pathology; Genotype","score_opus":0.3330410630973113,"score_gpt":0.5339622308067224,"score_spread":0.20092116770941115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037050175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027831607,0.992187,0.000010684924,0.00017275504,0.002529924,0.001269116,0.00031838572,0.00006686608,0.0006620677],"genre_scores_gemma":[0.0005300961,0.994239,0.00017232826,0.0031462407,0.0010202248,0.00027182902,0.0001282394,0.00009216334,0.0003998807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966436,0.0008244162,0.001082698,0.0006551059,0.00024896848,0.00054520887],"domain_scores_gemma":[0.997894,0.00025509705,0.00096592243,0.00023631855,0.00015972902,0.00048894185],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005842361,0.00068430294,0.0016743571,0.0003567567,0.00014923199,0.000019983654,0.00047512678,0.0008169269,0.0011238538],"category_scores_gemma":[0.000021475298,0.00065481965,0.00031099023,0.00053597236,0.00056589674,0.000083374725,0.00011757189,0.0010433709,0.000038234743],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024321094,0.00008497806,0.000056968533,0.0054681725,0.0006782943,0.000005971726,0.000239837,0.000056702567,0.0021114757,0.000097470926,0.005051129,0.9861247],"study_design_scores_gemma":[0.0011417983,0.000052849817,0.000035109715,0.000854373,0.006123442,0.000023687042,0.0000055065057,0.0005850096,0.009021444,0.00038598676,0.98122317,0.0005476105],"about_ca_topic_score_codex":0.000011663201,"about_ca_topic_score_gemma":0.000001325444,"teacher_disagreement_score":0.98557705,"about_ca_system_score_codex":0.00012135144,"about_ca_system_score_gemma":0.0006010092,"threshold_uncertainty_score":0.99978924},"labels":[],"label_agreement":null},{"id":"W2052268895","doi":"10.3109/07357907.2011.626474","title":"Tumor Endothelial Marker 8 Overexpression in Breast Cancer Cells Enhances Tumor Growth and Metastasis","year":2011,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cancer research; Breast cancer; Metastasis; Biology; Phenotype; Cancer; Pathology; In vivo; Medicine; Internal medicine; Gene","score_opus":0.018284032326623633,"score_gpt":0.24710892409511098,"score_spread":0.22882489176848736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052268895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978963,0.0012785988,0.000031992513,0.00005708096,0.0001577878,0.00016942926,0.00023004605,0.000015062868,0.00016371121],"genre_scores_gemma":[0.99805343,0.00017408545,0.0006581486,0.0005593446,0.00025373985,0.00019371652,0.000030849536,0.000024583356,0.00005210763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901646,0.00007946417,0.00020532428,0.00037370357,0.00012517924,0.00019986393],"domain_scores_gemma":[0.99952024,0.000010404655,0.00013115686,0.00015656574,0.000057160152,0.00012444299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089698224,0.00016414824,0.00013228851,0.000053584637,0.000056109864,0.000020457692,0.00012238619,0.000055054446,0.00017586788],"category_scores_gemma":[0.000030414476,0.0001528686,0.000035423254,0.0000891821,0.00016238984,0.000019107198,0.00006346038,0.00006886613,0.0000029928647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014558782,0.000028023725,0.046025064,0.00008256449,0.000022162152,0.000002677054,0.000163464,0.000016710615,0.9522815,0.00001621975,0.0006512655,0.00056481274],"study_design_scores_gemma":[0.00038173003,0.00002489312,0.07770324,0.00020892841,0.000022771324,0.000003914239,0.000038224323,0.000037972844,0.92090076,0.00020455636,0.00029164582,0.00018135998],"about_ca_topic_score_codex":0.0007446174,"about_ca_topic_score_gemma":0.0000971074,"teacher_disagreement_score":0.03167817,"about_ca_system_score_codex":0.000027682434,"about_ca_system_score_gemma":0.00018994848,"threshold_uncertainty_score":0.62338006},"labels":[],"label_agreement":null},{"id":"W2058582200","doi":"10.1080/07357900600705599","title":"Metronomic Dosing of Chemotherapy: Applications in Pediatric Oncology","year":2006,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Naturopathic Medicine; Hospital for Sick Children","funders":"","keywords":"Medicine; Dosing; Chemotherapy; Oncology; Intensive care medicine; Pediatric oncology; Pediatric cancer; Refractory (planetary science); Clinical trial; Cancer; Internal medicine","score_opus":0.08034483980473799,"score_gpt":0.4158822447315223,"score_spread":0.3355374049267843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058582200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036682093,0.99415827,0.000016690414,0.00006525955,0.000044471246,0.0014493335,0.000030470785,0.000018293174,0.00054900703],"genre_scores_gemma":[0.0005651259,0.99743545,0.00035307175,0.000029886633,0.00023987045,0.0008725693,0.0002996807,0.00003572811,0.0001686255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890625,0.0000788497,0.00044435833,0.0002655292,0.0001331739,0.00017185941],"domain_scores_gemma":[0.99922365,0.00010634906,0.00032177346,0.00020678499,0.00004534557,0.000096078336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009542216,0.00017454596,0.000829567,0.000471076,0.000020777523,0.000005267982,0.00007782429,0.00016185695,0.000022704982],"category_scores_gemma":[0.000017546772,0.00014581167,0.00013974444,0.0006752034,0.00008075399,0.00003763293,0.00001615572,0.00023114965,0.0000138731175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010964635,0.00014091561,0.0047192234,0.012115588,0.00007377374,0.000005139831,0.000024686666,0.000005356313,0.000015153557,0.000056093657,0.00050332345,0.9823298],"study_design_scores_gemma":[0.0014928491,0.00023035053,0.005443878,0.0029811456,0.0011879958,0.000010531627,0.000004591779,0.000015919237,0.00024446938,0.00020281918,0.98798263,0.00020279003],"about_ca_topic_score_codex":0.00020106045,"about_ca_topic_score_gemma":0.000057815447,"teacher_disagreement_score":0.9874793,"about_ca_system_score_codex":0.0008883485,"about_ca_system_score_gemma":0.0015280257,"threshold_uncertainty_score":0.59460276},"labels":[],"label_agreement":null},{"id":"W2071750676","doi":"10.3109/07357900009012182","title":"Introduction: Management of Cancer in the Canadian Healthcare System","year":2000,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Health care; Cancer; Healthcare system; Medicine; Internal medicine; Political science","score_opus":0.03743421111468144,"score_gpt":0.24845337335005468,"score_spread":0.21101916223537326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071750676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86380166,0.01783606,0.000021121861,0.05713543,0.0014725069,0.00076967006,0.00044596626,0.00003145425,0.05848612],"genre_scores_gemma":[0.9958638,0.0012464763,0.00007186565,0.0010465179,0.00058490445,0.00021067994,0.000013681711,0.000012426766,0.00094962335],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99896896,0.000017189914,0.0004789398,0.00025750254,0.000037316015,0.00024008824],"domain_scores_gemma":[0.99943054,0.000006354067,0.00018815193,0.00025350729,0.000029924759,0.0000914989],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039229845,0.00010050858,0.00021692163,0.00013667229,0.00011118977,0.000036919886,0.00020123315,0.00007713174,0.0010050352],"category_scores_gemma":[0.000004357769,0.000101916194,0.000040512095,0.0003534455,0.00008812647,0.00020702908,0.000005703336,0.00011922686,0.000107680564],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019854067,0.000011436305,0.13449101,0.00038247876,0.000050972227,0.000003941508,0.002121789,0.004347209,0.000002153562,0.81003386,0.008484145,0.04005114],"study_design_scores_gemma":[0.00064043683,0.00003968061,0.65952426,0.0002735468,0.000017094717,0.000002835577,0.00061359775,0.0011956729,0.00010392002,0.01646665,0.32080185,0.00032040937],"about_ca_topic_score_codex":0.38354218,"about_ca_topic_score_gemma":0.31418997,"teacher_disagreement_score":0.79356724,"about_ca_system_score_codex":0.0009878199,"about_ca_system_score_gemma":0.00015251734,"threshold_uncertainty_score":0.9999082},"labels":[],"label_agreement":null},{"id":"W2077304538","doi":"10.1081/cnv-120014886","title":"The New Bisphosphonate, Zometa<sup>®</sup>(Zoledronic Acid), Decreases Skeletal Complications in Both Osteolytic and Osteoblastic Lesions: A Comparison to Pamidronate","year":2002,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Bone health and treatments","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Zoledronic acid; Medicine; Placebo; Breast cancer; Bisphosphonate; Prostate cancer; Chemotherapy; Internal medicine; Clinical endpoint; Urology; Hormonal therapy; Metastatic breast cancer; Surgery; Oncology; Gastroenterology; Cancer; Clinical trial; Osteoporosis; Pathology","score_opus":0.08590388979322759,"score_gpt":0.37001901199799103,"score_spread":0.2841151222047634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077304538","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026677754,0.9918261,0.000035965713,0.0017599774,0.00013815872,0.0032943878,0.0000710318,0.000083451174,0.00012310929],"genre_scores_gemma":[0.006697057,0.9881282,0.0004097083,0.0006993665,0.00007247837,0.0023227886,0.00034120298,0.000089228284,0.0012399568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704826,0.00019594813,0.0010957256,0.00069581857,0.00037385305,0.00059037877],"domain_scores_gemma":[0.99740815,0.0004986584,0.00042090617,0.000601451,0.000086759275,0.0009840585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019953297,0.0005551626,0.001413827,0.00034996713,0.00033509778,0.00007976204,0.00020188194,0.00028189947,0.00006215526],"category_scores_gemma":[0.0003251722,0.0003973762,0.00018095395,0.0011134018,0.00023745235,0.00011630633,0.00008412748,0.0005722772,0.00019334265],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002513905,0.00008004499,0.0012247156,0.0033879683,0.00014802934,0.00000964584,0.00029554882,0.0000698579,8.577245e-7,0.00018392678,0.004106377,0.9904679],"study_design_scores_gemma":[0.0018198083,0.00035100325,0.0073132804,0.020313608,0.0016668846,0.000102811726,0.00006398236,0.0019537401,0.000007343675,0.00030020825,0.9656212,0.0004861488],"about_ca_topic_score_codex":0.0018166763,"about_ca_topic_score_gemma":0.001360353,"teacher_disagreement_score":0.9899817,"about_ca_system_score_codex":0.0009863133,"about_ca_system_score_gemma":0.001875204,"threshold_uncertainty_score":0.9998478},"labels":[],"label_agreement":null},{"id":"W2089602338","doi":"10.3109/07357900009012184","title":"Canadian Healthcare System's Management of Patients with Cancer","year":2000,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Health care; Medicine; Cancer; Healthcare system; Intensive care medicine; Internal medicine; Political science","score_opus":0.023111485446793277,"score_gpt":0.2146812301005449,"score_spread":0.19156974465375162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089602338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696061,0.0030647747,0.00002949618,0.0015424914,0.0003826387,0.0004282635,0.0011035425,0.000028592673,0.02381412],"genre_scores_gemma":[0.9968564,0.00059076684,0.0002191136,0.00066636805,0.00009203209,0.00015445337,0.000058500744,0.000025918105,0.0013364825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989332,0.000007088983,0.0004333348,0.0002934095,0.00004118452,0.00029180292],"domain_scores_gemma":[0.99920064,0.000004229266,0.00026337375,0.00022436498,0.000069574824,0.00023782115],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000108561064,0.00013536047,0.00028427676,0.00013044607,0.00009412961,0.00002515721,0.00014620085,0.000077416655,0.001119587],"category_scores_gemma":[0.000002111718,0.00014801248,0.00003785743,0.00022867927,0.00007121556,0.00027619523,0.0000072641956,0.000075942524,0.000102753176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043199834,0.000012788427,0.8749225,0.00039528788,0.000094196985,0.00000136616,0.0003810451,0.0011765229,3.660495e-7,0.09931538,0.0016614528,0.021995893],"study_design_scores_gemma":[0.0009113843,0.000063527776,0.94800353,0.00038074388,0.000019784224,1.9450329e-7,0.000065089545,0.00028806686,0.000052611802,0.0028182117,0.047093432,0.0003033926],"about_ca_topic_score_codex":0.27315593,"about_ca_topic_score_gemma":0.05597903,"teacher_disagreement_score":0.2171769,"about_ca_system_score_codex":0.0011256023,"about_ca_system_score_gemma":0.00018857815,"threshold_uncertainty_score":0.9997935},"labels":[],"label_agreement":null},{"id":"W2089980833","doi":"10.3109/07357907.2011.606250","title":"Two-Year Clinical Experience With Tomotherapy: The French National Cancer Institute Project on Implementing New Technology","year":2011,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Tomotherapy; Medicine; Toxicity; Chronic toxicity; Radiation therapy; Acute toxicity; Cancer; Head and neck cancer; Surgery; Internal medicine","score_opus":0.09731402318494221,"score_gpt":0.4033981589609579,"score_spread":0.3060841357760157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089980833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9373026,0.00016367456,0.052660912,0.0014520558,0.00042176186,0.0010394922,0.00003698498,0.00025905733,0.006663469],"genre_scores_gemma":[0.9487498,0.000041469946,0.047829136,0.00096819043,0.0010448833,0.0009844191,0.000014436004,0.000033277203,0.00033438398],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899197,0.000032950258,0.00025264756,0.00030466996,0.00019797144,0.0002197788],"domain_scores_gemma":[0.99938154,0.00002153175,0.00022006553,0.00021326338,0.000116078394,0.000047525828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014950856,0.00014902456,0.00013285989,0.00007931145,0.00017470629,0.00002314317,0.00023564736,0.00004300637,0.0003462365],"category_scores_gemma":[0.000007925485,0.00010230572,0.000036274014,0.00036904603,0.00034572763,0.00025432298,0.000024351211,0.00022068477,0.0000019222948],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035741094,0.00003867427,0.8107312,0.0000039349266,0.00011142881,4.3524108e-7,0.003478258,0.00010095151,0.0010599148,0.09529058,0.0027975186,0.08635139],"study_design_scores_gemma":[0.0075140586,0.0013764328,0.1208332,0.00083711895,0.000138189,0.000005861547,0.0036720496,0.0015745346,0.3380179,0.21875547,0.30515304,0.002122134],"about_ca_topic_score_codex":0.0033637225,"about_ca_topic_score_gemma":0.00030378884,"teacher_disagreement_score":0.68989795,"about_ca_system_score_codex":0.00009778753,"about_ca_system_score_gemma":0.0006037974,"threshold_uncertainty_score":0.50849646},"labels":[],"label_agreement":null},{"id":"W2095581747","doi":"10.1081/cnv-120027578","title":"Action of Troxacitabine on Cells Transduced with Human Cytidine Deaminase cDNA","year":2004,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cytidine deaminase; Cytidine; Activation-induced (cytidine) deaminase; Complementary DNA; Action (physics); Cytosine deaminase; Molecular biology; Chemistry; Biology; DNA; Genetics; Gene; Enzyme; Biochemistry; Genetic enhancement; Physics; Antibody","score_opus":0.0508670018797453,"score_gpt":0.3002596755784858,"score_spread":0.24939267369874052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095581747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701047,0.00005828598,0.00034860487,0.0010462574,0.00011145083,0.00027883932,0.000009592551,0.00005754582,0.001078976],"genre_scores_gemma":[0.9981447,0.000019815405,0.00053763384,0.0006227574,0.00013723115,0.000052606036,0.00006413013,0.000016942655,0.00040418282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992904,0.000016756689,0.0001883925,0.00017771013,0.00020818616,0.00011853577],"domain_scores_gemma":[0.99948853,0.000018603625,0.00010274539,0.00016343645,0.00009867557,0.00012799959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069054826,0.00011680311,0.00020458251,0.00010712293,0.00005095676,0.0000054071897,0.000026245856,0.000056575584,0.00011265431],"category_scores_gemma":[0.000023561788,0.00009258244,0.00003960109,0.00023322632,0.00011374123,0.00008697634,0.0000019436031,0.00009329189,0.000010877356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002152902,0.00007517063,0.0035557197,0.00015370073,0.00003716958,0.0000022456925,0.00028816125,0.0012427819,0.9922689,0.00078909314,0.0001600547,0.0012117043],"study_design_scores_gemma":[0.0034512905,0.0009434141,0.02522642,0.0003962366,0.00013298064,0.000002700021,0.00008647923,0.000077609046,0.9689268,0.00048742196,0.0001763123,0.00009234866],"about_ca_topic_score_codex":0.00018253247,"about_ca_topic_score_gemma":0.000027869726,"teacher_disagreement_score":0.023342121,"about_ca_system_score_codex":0.00018229372,"about_ca_system_score_gemma":0.00016858744,"threshold_uncertainty_score":0.37754023},"labels":[],"label_agreement":null},{"id":"W2097919720","doi":"10.3109/07357907.2014.880452","title":"Association of Aromatase Inhibitors With Coronary Heart Disease in Women With Early Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Coronary artery disease; Breast cancer; Tamoxifen; Internal medicine; Hazard ratio; Oncology; Aromatase; Population; Cardiology; Letrozole; Aromatase inhibitor; Hormonal therapy; Cancer; Confidence interval","score_opus":0.0034291750784833327,"score_gpt":0.20588743443224386,"score_spread":0.20245825935376052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097919720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859387,0.00032899968,0.00001048479,0.000753146,0.000047142763,0.000180107,0.000060259168,0.000008524662,0.000017486947],"genre_scores_gemma":[0.9991586,0.00004130557,0.000050282903,0.00031187458,0.00010724072,0.00015523391,0.00007518968,0.000016477461,0.00008380289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999309,0.000069719215,0.00012115389,0.00019551764,0.0001428587,0.00016173252],"domain_scores_gemma":[0.99954647,0.000008670256,0.00012458963,0.00012744512,0.0000668475,0.0001259924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121276404,0.000102203405,0.00010818792,0.00003569184,0.000028657769,0.000008850195,0.000046452435,0.00008779244,0.000006728497],"category_scores_gemma":[0.000014524929,0.00008075369,0.0000136383605,0.00013468748,0.00007450628,0.000011683451,0.000013451395,0.00007813632,0.000001326572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007318171,0.00002563361,0.87535167,0.000041612537,0.00004731332,0.0000012128402,0.00012738649,0.0017609529,0.12045186,0.000007993744,0.0008337528,0.0006187915],"study_design_scores_gemma":[0.0010473183,0.000354187,0.9379272,0.0001916449,0.000034168144,0.0000021878386,0.000017426008,0.0001200871,0.059793934,0.000053071275,0.00030854417,0.00015026929],"about_ca_topic_score_codex":0.00034052038,"about_ca_topic_score_gemma":0.000095879754,"teacher_disagreement_score":0.06257549,"about_ca_system_score_codex":0.00011508369,"about_ca_system_score_gemma":0.00019235328,"threshold_uncertainty_score":0.32930398},"labels":[],"label_agreement":null},{"id":"W2100197588","doi":"10.1081/cnv-120002497","title":"Defining Clinically Meaningful Outcomes in the Evaluation of New Treatments for Oral Mucositis: Oral Mucositis Patient Provider Advisory Board","year":2002,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mucositis; Medicine; Clinical trial; Oral mucosa; Intensive care medicine; Quality of life (healthcare); Oral medicine; Patient-reported outcome; Internal medicine; Dentistry; Chemotherapy; Pathology","score_opus":0.21753816875662835,"score_gpt":0.433815753166602,"score_spread":0.21627758440997363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100197588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847951,0.0033066475,0.00006347235,0.0075937775,0.00045618662,0.0034066383,0.000054831842,0.00004154298,0.00028182106],"genre_scores_gemma":[0.9850686,0.00015350539,0.008795872,0.003911938,0.00010769174,0.0016693348,0.00009367403,0.000034861892,0.0001645291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729824,0.00027498286,0.00087778346,0.00039375995,0.00080658816,0.0003486603],"domain_scores_gemma":[0.9984638,0.00023399269,0.00044719424,0.00034027704,0.00032565638,0.00018904834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080829335,0.0002301647,0.00046197756,0.00011912062,0.000092167626,0.00001973656,0.000099156925,0.00012899694,0.00014105818],"category_scores_gemma":[0.0004338137,0.00016931814,0.00012713796,0.00028426244,0.00010026718,0.00019345358,0.000018183782,0.00015552579,0.000013771207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002262961,0.00029334545,0.5234655,0.00015223645,0.00016448241,0.0000042312195,0.006852156,0.00043450834,0.000069886155,0.00013249715,0.0047502546,0.46345457],"study_design_scores_gemma":[0.023251634,0.0062977215,0.925677,0.0018105458,0.0026638948,0.000015670168,0.0015143738,0.02731084,0.004072392,0.0050772247,0.0018207823,0.0004879201],"about_ca_topic_score_codex":0.0020524778,"about_ca_topic_score_gemma":0.0008532243,"teacher_disagreement_score":0.46296665,"about_ca_system_score_codex":0.0012864091,"about_ca_system_score_gemma":0.0007469933,"threshold_uncertainty_score":0.6904594},"labels":[],"label_agreement":null},{"id":"W2101857408","doi":"10.1081/cnv-100102548","title":"Mitoxantrone and Paclitaxel Combination Chemotherapy in Metastatic Breast Cancer","year":2001,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"Bristol-Myers Squibb","keywords":"Mitoxantrone; Medicine; Chemotherapy; Cardiotoxicity; Metastatic breast cancer; Internal medicine; Neutropenia; Regimen; Oncology; Breast cancer; Nausea; Doxorubicin; Paclitaxel; Cancer; Progressive disease; Surgery","score_opus":0.03761453095331926,"score_gpt":0.3490888451618517,"score_spread":0.31147431420853244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101857408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746554,0.0029540358,0.000015521277,0.021485351,0.00019480592,0.00042130562,0.000022575441,0.00003052329,0.00022047485],"genre_scores_gemma":[0.9919703,0.0038269095,0.00013191265,0.0028236662,0.00017057889,0.00027893338,0.00004472844,0.000016599093,0.00073635764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999304,0.00003782228,0.00017393516,0.00020392855,0.000116127674,0.00016416587],"domain_scores_gemma":[0.9996521,0.000029222849,0.00007233716,0.0000786413,0.00006064557,0.00010704211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000880089,0.000116724164,0.00020149024,0.00011321014,0.000037917875,0.000011738576,0.000024871679,0.000043875032,0.00048690283],"category_scores_gemma":[0.0000064997985,0.00010693759,0.00002321571,0.00027497046,0.0001077492,0.00013478474,0.0000065511204,0.00009842083,0.000004272574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052118243,0.00021708113,0.8885489,0.000115873925,0.00012452411,0.000021469685,0.001160738,0.00004296688,0.041171048,0.00036144635,0.0032395008,0.06447525],"study_design_scores_gemma":[0.007193965,0.0001333381,0.9822919,0.00014382838,0.00014813455,0.000053440424,0.00007087882,0.0014677122,0.004333536,0.0014020626,0.002635401,0.0001258002],"about_ca_topic_score_codex":0.0015886625,"about_ca_topic_score_gemma":0.0006615121,"teacher_disagreement_score":0.09374299,"about_ca_system_score_codex":0.0003214168,"about_ca_system_score_gemma":0.00014121222,"threshold_uncertainty_score":0.53312445},"labels":[],"label_agreement":null},{"id":"W2101868054","doi":"10.1081/cnv-100103843","title":"Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Etoposide (CHOPE) for Advanced-Stage Hodgkin's Disease: CALGB 8856","year":2001,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care","funders":"National Cancer Institute","keywords":"Vincristine; Medicine; Procarbazine; Etoposide; Dacarbazine; Prednisone; ABVD; Internal medicine; Vinblastine; Regimen; Cyclophosphamide; Surgery; Gastroenterology; Cohort; Chemotherapy; Oncology; Urology","score_opus":0.025525111102034332,"score_gpt":0.30861721996975455,"score_spread":0.28309210886772024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101868054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803874,0.010167559,0.00039385096,0.006433749,0.00029411848,0.0014664738,0.00019027079,0.000120470235,0.0005461284],"genre_scores_gemma":[0.98492885,0.0032781472,0.003092216,0.0030394893,0.00031725617,0.0014292572,0.00033303513,0.000046869216,0.003534883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986454,0.00002441422,0.00030459638,0.00048162616,0.00023208534,0.00031182836],"domain_scores_gemma":[0.9988126,0.000091743685,0.00014214253,0.00029765497,0.00016215802,0.0004937031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009614251,0.0002461912,0.00030515512,0.00007152997,0.00016813859,0.000042209853,0.000057587764,0.000081506594,0.000070246155],"category_scores_gemma":[0.0001724955,0.00021376077,0.00008224139,0.00019730357,0.00013255086,0.00019415682,0.000029329021,0.00007077291,0.000009509956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008967139,0.00018468029,0.93473625,0.0004711867,0.00013902353,0.00009376138,0.000270817,0.00031668908,0.0055331257,0.0026281986,0.0122108795,0.04251865],"study_design_scores_gemma":[0.006740797,0.0003478787,0.865709,0.00057647424,0.00048353578,0.000020226367,0.00008132681,0.0015326445,0.021581829,0.0016836156,0.10088148,0.0003611908],"about_ca_topic_score_codex":0.0004932831,"about_ca_topic_score_gemma":0.00012769391,"teacher_disagreement_score":0.088670604,"about_ca_system_score_codex":0.00037672598,"about_ca_system_score_gemma":0.000308072,"threshold_uncertainty_score":0.8716911},"labels":[],"label_agreement":null},{"id":"W2101907056","doi":"10.1081/cnv-120001183","title":"Applications of SKY in Cancer Cytogenetics","year":2002,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cytogenetics; Fluorescence in situ hybridization; Molecular cytogenetics; Biology; Karyotype; Cancer; Computational biology; Pathology; Chromosome; Genetics; Gene; Medicine","score_opus":0.05758597888379116,"score_gpt":0.3281223273917117,"score_spread":0.2705363485079205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101907056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006895401,0.9979352,0.00011376502,0.000021448648,0.00010552171,0.00051873864,0.00031174216,0.0000051506454,0.00029890527],"genre_scores_gemma":[0.0013011973,0.9951638,0.00025041518,0.000041048293,0.00033934167,0.0015427183,0.00046254587,0.00003128387,0.0008676759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989502,0.000058273185,0.00047199713,0.0002854396,0.00008823807,0.00014588339],"domain_scores_gemma":[0.99923193,0.0000091277225,0.0003321315,0.00029613526,0.000079406454,0.000051253435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006755663,0.00019483492,0.0004142913,0.00010005692,0.00003245798,0.000010458334,0.00019642654,0.0002673077,0.000083662984],"category_scores_gemma":[0.000010586412,0.00019241155,0.00012467192,0.0002573794,0.00009280688,0.0000028042189,0.000053225885,0.00010020555,0.000007742896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000026347604,0.000054644042,0.0015737112,0.008948351,0.00016525185,4.619515e-7,0.00017940569,0.0003904998,0.0004761229,0.0006890386,0.0015063178,0.98601353],"study_design_scores_gemma":[0.00009861687,0.000022764902,0.000048944705,0.0011580152,0.00015358624,0.0000023340654,0.000014142021,0.000008978118,0.0012199479,0.00010119965,0.9969661,0.00020534226],"about_ca_topic_score_codex":0.00019254023,"about_ca_topic_score_gemma":0.00021214868,"teacher_disagreement_score":0.9954598,"about_ca_system_score_codex":0.000086682005,"about_ca_system_score_gemma":0.00042071252,"threshold_uncertainty_score":0.7846315},"labels":[],"label_agreement":null},{"id":"W2103523021","doi":"10.3109/07357907.2014.958232","title":"Increased Expression of Tumor Proliferation Genes in Hispanic Women with Early-Stage Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute; National Institutes of Health; National Center for Advancing Translational Sciences; Genomic Health","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Oncology; Internal medicine; Cancer; Gynecology; Biology","score_opus":0.00984091592139721,"score_gpt":0.23602048796443184,"score_spread":0.22617957204303463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103523021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875563,0.0004621306,0.000112888745,0.00022775696,0.00006088714,0.00024515693,0.00008108532,0.000012832029,0.00004163409],"genre_scores_gemma":[0.9983032,0.00011297146,0.00023966278,0.00025119632,0.00020574262,0.000760123,0.000056670648,0.000022986973,0.000047477235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907756,0.00007825566,0.00019442204,0.00030721893,0.00014772211,0.00019483216],"domain_scores_gemma":[0.99942726,0.00000904937,0.0001754012,0.00020373214,0.00010919499,0.00007534231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001087558,0.00015764686,0.00017516108,0.000054901444,0.00005110303,0.000011184651,0.00008365167,0.00006158397,0.000029278835],"category_scores_gemma":[0.000017463693,0.00013116552,0.000018485214,0.00014122085,0.000121831865,0.000016550906,0.000035521512,0.000050200906,9.630159e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033809923,0.00002535424,0.57237655,0.00005894541,0.000023539278,3.638539e-7,0.00036181643,0.0006900286,0.42479107,0.000022733971,0.00006462513,0.0012468622],"study_design_scores_gemma":[0.00092933385,0.00010874405,0.5911227,0.00012334455,0.000013303689,0.000001814875,0.000059086087,0.000096711934,0.40712067,0.000036596175,0.0002623824,0.00012532006],"about_ca_topic_score_codex":0.0015160501,"about_ca_topic_score_gemma":0.0010314262,"teacher_disagreement_score":0.018746123,"about_ca_system_score_codex":0.00014472027,"about_ca_system_score_gemma":0.00017512064,"threshold_uncertainty_score":0.5348775},"labels":[],"label_agreement":null},{"id":"W2120007701","doi":"10.1080/07357900701560612","title":"Serum Vascular Endothelial Growth Factor (VEGF) Levels Correlate with Tumor VEGF and p53 Overexpression in Endocrine Positive Primary Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal","funders":"","keywords":"Vascular endothelial growth factor; Angiogenesis; Breast cancer; Medicine; Internal medicine; Endocrine system; Immunohistochemistry; Cancer; Basal (medicine); Microvessel; Neovascularization; Endocrinology; Pathology; Oncology; VEGF receptors; Hormone","score_opus":0.01540441150640647,"score_gpt":0.23601022091869628,"score_spread":0.2206058094122898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120007701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570066,0.002610017,0.00008382838,0.0002689396,0.00011333871,0.00029000462,0.00080309855,0.000015132323,0.00011499013],"genre_scores_gemma":[0.99633104,0.0016038782,0.00017416113,0.0010417036,0.00035871967,0.00015307784,0.000107426225,0.00004055365,0.00018945847],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99876904,0.00006431274,0.00020998041,0.00047544745,0.00020168535,0.0002795434],"domain_scores_gemma":[0.9994032,0.000012940787,0.00013588356,0.00017806666,0.00013496865,0.00013495686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048763846,0.00023819933,0.00021343271,0.00005749126,0.00012232653,0.000017047467,0.00010105941,0.00008736749,0.00007355625],"category_scores_gemma":[0.000012772428,0.00020169614,0.000056911893,0.00013327812,0.00022844208,0.00002964573,0.00006870329,0.000117102274,0.0000016337359],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022822504,0.000029378969,0.3206449,0.00008328338,0.00008173953,0.00002106832,0.00030582593,0.00019806136,0.67680764,0.00004229274,0.00036301097,0.0011945736],"study_design_scores_gemma":[0.0012934065,0.00009543855,0.68889093,0.00033067632,0.000022828382,0.000084012165,0.000024428204,0.00006980366,0.30839103,0.000039119484,0.00048319815,0.0002751157],"about_ca_topic_score_codex":0.00069064205,"about_ca_topic_score_gemma":0.0001262331,"teacher_disagreement_score":0.36841664,"about_ca_system_score_codex":0.00012618794,"about_ca_system_score_gemma":0.00036460874,"threshold_uncertainty_score":0.822493},"labels":[],"label_agreement":null},{"id":"W2135706959","doi":"10.1080/07357900902996441","title":"Cancer and Thrombosis: Back to the Future<i>Renewed Interest in an Old Problem</i>","year":2009,"lang":"en","type":"letter","venue":"Cancer Investigation","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cancer; Thrombosis; Ambulatory; Randomized controlled trial; Venous thromboembolism; Metastasis; Intensive care medicine; Surgery; Internal medicine; Oncology","score_opus":0.06534462197541314,"score_gpt":0.31311535374578825,"score_spread":0.24777073177037512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135706959","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15955137,0.002631555,0.0000042545607,0.83453614,0.00079779926,0.0019943686,0.000043485463,0.000050292994,0.0003907696],"genre_scores_gemma":[0.010693605,0.0035137204,0.00039324773,0.97383904,0.008757871,0.0013281478,0.00032910274,0.00007817053,0.0010670638],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980512,0.00010144716,0.0004344393,0.00069427356,0.0002878049,0.00043078169],"domain_scores_gemma":[0.99892336,0.000024621997,0.0002007426,0.0005495468,0.00011814012,0.00018357339],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000220529,0.0003945873,0.0006635195,0.00022365393,0.00009089885,0.00012286597,0.00024660534,0.0004015916,0.0001774544],"category_scores_gemma":[0.00001208651,0.00029070806,0.000065498505,0.00039261076,0.00011425567,0.00018058416,0.0000771347,0.00090933684,0.000033624005],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011622466,0.00004392704,0.0042151753,0.0004610105,0.0000836147,0.000013867654,0.0013744008,0.0000866781,0.0002854522,0.0001546229,0.98078436,0.012485301],"study_design_scores_gemma":[0.00071679504,0.00031417303,0.115210995,0.002433927,0.00037634638,0.000002991613,0.00013457789,0.00006408746,0.00037588135,0.0009025005,0.87904984,0.00041790277],"about_ca_topic_score_codex":0.0024813036,"about_ca_topic_score_gemma":0.014405426,"teacher_disagreement_score":0.14885776,"about_ca_system_score_codex":0.00041566198,"about_ca_system_score_gemma":0.00023273505,"threshold_uncertainty_score":0.9999545},"labels":[],"label_agreement":null},{"id":"W2138581078","doi":"10.3109/07357907.2014.889706","title":"Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Medicine; Metformin; Overweight; Breast cancer; Cancer; Obesity; Internal medicine; Oncology; Clinical trial; Gynecology; Insulin","score_opus":0.007382633654831579,"score_gpt":0.2316883924968264,"score_spread":0.22430575884199483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138581078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853454,0.01392593,0.000024570649,0.000037306832,0.0001898613,0.00031349307,0.000072975396,0.0000040861723,0.000086362845],"genre_scores_gemma":[0.99168074,0.007220368,0.00012545625,0.00027948694,0.0003518499,0.00021550636,0.000080600235,0.000015695376,0.000030308547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991436,0.0000731265,0.00020857701,0.000259276,0.00015983614,0.0001556073],"domain_scores_gemma":[0.9994951,0.000016732334,0.00013415018,0.00016264361,0.00009874611,0.00009266724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001447553,0.0001224981,0.00019101973,0.00003928883,0.000026189458,0.000011381436,0.000074828946,0.0001015995,0.00003426054],"category_scores_gemma":[0.000046903104,0.000098001365,0.000026936326,0.0001075059,0.00013435195,0.000014208012,0.000027038519,0.00005875141,3.572699e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008715397,0.00023090125,0.5370706,0.00021421933,0.000109523404,6.8145e-7,0.0004459117,0.00062134716,0.009677865,0.00042740878,0.0017136069,0.44077253],"study_design_scores_gemma":[0.097452134,0.0010129251,0.7229793,0.0004028222,0.00015611334,0.000001145822,0.000039803912,0.0005686431,0.09732711,0.0010889603,0.078258365,0.00071268063],"about_ca_topic_score_codex":0.00039585488,"about_ca_topic_score_gemma":0.0005645577,"teacher_disagreement_score":0.44005987,"about_ca_system_score_codex":0.00002314362,"about_ca_system_score_gemma":0.00012970992,"threshold_uncertainty_score":0.39963797},"labels":[],"label_agreement":null},{"id":"W2143264131","doi":"10.3109/07357907.2010.512597","title":"Clinical Significance of GPR56, Transglutaminase 2, and NF-κB in Esophageal Squamous Cell Carcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Blood properties and coagulation","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Council of Scientific and Industrial Research, India; Department of Science and Technology, Ministry of Science and Technology, India","keywords":"Tissue transglutaminase; Tissue microarray; Immunostaining; Immunohistochemistry; Pathology; Esophageal squamous cell carcinoma; Cancer research; Metastasis; Biology; Carcinoma; Medicine; Cancer; Internal medicine; Enzyme","score_opus":0.03536236357715308,"score_gpt":0.29608232036733617,"score_spread":0.2607199567901831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143264131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976287,0.00081987004,0.000027612534,0.0006666123,0.00022394158,0.00034550106,0.0000074958584,0.000015030362,0.00026522152],"genre_scores_gemma":[0.99853516,0.000026884338,0.0006325831,0.00035696468,0.00019405647,0.000041327967,0.000013749788,0.00001351844,0.00018576984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910235,0.000046058416,0.00037442328,0.00022147958,0.00013390022,0.00012177038],"domain_scores_gemma":[0.9994799,0.000052169773,0.00010485893,0.00016305108,0.00007523729,0.00012476763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025438252,0.00009343413,0.00021969243,0.000058301022,0.000026010579,0.000006715907,0.00004233183,0.00013542546,0.000049593295],"category_scores_gemma":[0.00005728035,0.00008392577,0.00003688955,0.0001456351,0.00023660595,0.00008670917,0.000009069216,0.00027249428,0.0000018295934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012243992,0.00006637766,0.84786487,0.00026147012,0.000003210615,0.000006556196,0.00071764627,0.000024407524,0.13409404,0.0001521885,0.00009057472,0.016596252],"study_design_scores_gemma":[0.0018124911,0.00023302346,0.8171954,0.000038695583,0.00005944906,0.0000040213063,0.00006937196,0.0032032062,0.17685457,0.00025545582,0.00018606625,0.00008824378],"about_ca_topic_score_codex":0.00075322174,"about_ca_topic_score_gemma":0.00039399826,"teacher_disagreement_score":0.04276052,"about_ca_system_score_codex":0.00001963111,"about_ca_system_score_gemma":0.00019877167,"threshold_uncertainty_score":0.34223935},"labels":[],"label_agreement":null},{"id":"W2156495442","doi":"10.1081/cnv-120005901","title":"Low Molecular Weight Heparin for Venous Thromboembolism Prophylaxis in Urologic Oncologic Surgery","year":2002,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Hematocrit; Low molecular weight heparin; Surgery; Venous thrombosis; Prospective cohort study; Anesthesia; Thrombosis; Internal medicine","score_opus":0.050237268664268565,"score_gpt":0.2820849420657845,"score_spread":0.23184767340151594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156495442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898908,0.0022022943,0.00015526768,0.004352544,0.00054491014,0.0016164314,0.000009422502,0.000102968304,0.0011253344],"genre_scores_gemma":[0.99154216,0.00085927837,0.00055563095,0.0051654587,0.00026951733,0.0013903016,0.000052075484,0.000035758134,0.0001298456],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984173,0.00007198925,0.00040548466,0.0004487969,0.00024054288,0.00041587977],"domain_scores_gemma":[0.9991862,0.00011263559,0.00016083103,0.00029315622,0.00009600802,0.00015112577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030705048,0.000212941,0.00068019057,0.00023220833,0.00008212788,0.000025651001,0.00010145543,0.0001829984,0.00023722276],"category_scores_gemma":[0.00018763497,0.0001927662,0.00013772286,0.0004116699,0.0001349038,0.00011249343,0.00003570762,0.000179825,0.000040437208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003960509,0.0099241575,0.27984056,0.0060898596,0.001092937,0.0008826981,0.007993925,0.0070476257,0.06960256,0.020727549,0.20830244,0.38809964],"study_design_scores_gemma":[0.0053782267,0.004086948,0.8086146,0.0013472222,0.00083812326,0.000037823756,0.00021188246,0.013599754,0.090139404,0.021327367,0.05287146,0.0015471515],"about_ca_topic_score_codex":0.00019054252,"about_ca_topic_score_gemma":0.00007180301,"teacher_disagreement_score":0.5287741,"about_ca_system_score_codex":0.00033359992,"about_ca_system_score_gemma":0.00011339307,"threshold_uncertainty_score":0.78607774},"labels":[],"label_agreement":null},{"id":"W2157925255","doi":"10.3109/07357900903287030","title":"Interleukin-17F Suppresses Hepatocarcinoma Cell Growth via Inhibition of Tumor Angiogenesis","year":2010,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Angiogenesis; In vivo; Cancer research; Cell growth; Vascular endothelial growth factor; Cell; In vitro; Hepatocellular carcinoma; Biology; Interleukin 8; Microvessel; Interleukin; Transfection; Cell culture; Molecular biology; Immunology; Cytokine; VEGF receptors","score_opus":0.01184721748998662,"score_gpt":0.2349356368205134,"score_spread":0.22308841933052678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157925255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972487,0.0010316849,0.00062780164,0.00013142721,0.00041418037,0.00016526424,0.00006212548,0.000014299918,0.00030453654],"genre_scores_gemma":[0.99779654,0.00010274827,0.00075438945,0.00043988705,0.0004968359,0.00010790725,0.00017213897,0.000029477478,0.00010005931],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991073,0.000033674325,0.00024887786,0.000308366,0.00013136129,0.00017039792],"domain_scores_gemma":[0.9992254,0.000009130974,0.00018201748,0.00025961193,0.00022835868,0.00009549633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010379968,0.00015310095,0.00014044503,0.000060442406,0.000056869572,0.0000143157185,0.00012542702,0.00012845652,0.00009856008],"category_scores_gemma":[0.00003078086,0.00015134469,0.00011886436,0.00013750487,0.00018472671,0.000012195311,0.000056603494,0.00006649268,0.000005694667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028489067,0.000019619561,0.09815423,0.0000673576,0.000017185434,8.2644743e-7,0.000054015312,0.000016580108,0.89850557,0.00008106445,0.0025455183,0.0005095422],"study_design_scores_gemma":[0.00027232314,0.00009866867,0.024556568,0.000024455383,0.000035561,0.0000047670696,0.000022409151,0.000092451126,0.9723732,0.00029737139,0.0020499066,0.00017233279],"about_ca_topic_score_codex":0.00030419073,"about_ca_topic_score_gemma":0.00020765644,"teacher_disagreement_score":0.07386762,"about_ca_system_score_codex":0.000018706056,"about_ca_system_score_gemma":0.00014867615,"threshold_uncertainty_score":0.61716574},"labels":[],"label_agreement":null},{"id":"W2160584144","doi":"10.3109/07357900009012183","title":"Cancer Care in Ontario: Accessible Oncology on Sale, or Cheque's in the Mail?","year":2000,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Cheque; Medicine; Oncology; Family medicine; World Wide Web; Internal medicine; Computer science","score_opus":0.054360956730287784,"score_gpt":0.4205797911907594,"score_spread":0.3662188344604716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160584144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97345257,0.0022454904,0.0000035960204,0.0083694905,0.00045096572,0.00057941244,0.000005122756,0.000022946233,0.014870404],"genre_scores_gemma":[0.9597025,0.0024981045,0.0006650486,0.028661724,0.0005480604,0.00093213713,0.000038570364,0.000023653885,0.0069302097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989926,0.00012120725,0.00024749842,0.0002607896,0.00014997426,0.00022790732],"domain_scores_gemma":[0.9994985,0.0001344323,0.00007189321,0.00020380791,0.000033323675,0.00005805828],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017620916,0.00013272486,0.00025099656,0.00009857204,0.00006540526,0.000008341166,0.00014457581,0.00020301016,0.003459082],"category_scores_gemma":[0.000027654087,0.000083899526,0.000028826757,0.00036042926,0.00021571587,0.00013225462,0.00000568634,0.0005379557,0.000017297847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024371601,0.00013735192,0.68396086,0.00008562497,0.000031926687,0.00018335787,0.02767067,0.005008531,0.000493309,0.00029228587,0.0052251867,0.27447376],"study_design_scores_gemma":[0.0036609024,0.00077499595,0.63455224,0.00042533033,0.000032205313,0.000024634219,0.000797123,0.00011881716,0.0012600076,0.0008395135,0.35734695,0.00016725446],"about_ca_topic_score_codex":0.03204716,"about_ca_topic_score_gemma":0.65092814,"teacher_disagreement_score":0.618881,"about_ca_system_score_codex":0.0026879502,"about_ca_system_score_gemma":0.0019280772,"threshold_uncertainty_score":0.9974519},"labels":[],"label_agreement":null},{"id":"W2167810032","doi":"10.3109/07357900009031830","title":"Telomerase: Therapeutic Potential in Cancer","year":2000,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Telomerase; Cancer research; Medicine; Cancer; Telomere; Biology; Internal medicine; DNA; Genetics","score_opus":0.10807540078307784,"score_gpt":0.39189335267132314,"score_spread":0.2838179518882453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167810032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015125404,0.9954305,0.000005037912,0.00042227886,0.0007944867,0.0013297547,0.000091733265,0.00011206906,0.00030154453],"genre_scores_gemma":[0.00044272194,0.9941526,0.00007161729,0.0012169288,0.0010949043,0.00091499294,0.00034026487,0.00011533489,0.0016506251],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719924,0.0001817184,0.0008831954,0.0007524909,0.00046848293,0.0005149018],"domain_scores_gemma":[0.99869615,0.00006600122,0.00034295878,0.0005098042,0.00008582127,0.00029929087],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017300394,0.00058366836,0.0016876359,0.0005354265,0.000085299915,0.000046227313,0.00023196284,0.00052037503,0.0015194832],"category_scores_gemma":[0.000031613235,0.0004936581,0.00033874786,0.0011324774,0.00024969148,0.00015530031,0.000026611331,0.00079203414,0.00013151144],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002476747,0.000042543208,0.0004390055,0.008528489,0.000119261196,0.00006019491,0.0001677078,0.000019701243,0.000027218692,0.000029158251,0.0011918504,0.9893501],"study_design_scores_gemma":[0.00061122933,0.000053007512,0.00086634816,0.023785582,0.0011025853,0.000048509934,0.000016597907,0.00006325674,0.000052224696,0.00011830146,0.97274834,0.0005340013],"about_ca_topic_score_codex":0.0014108338,"about_ca_topic_score_gemma":0.00027805968,"teacher_disagreement_score":0.9888161,"about_ca_system_score_codex":0.0008342057,"about_ca_system_score_gemma":0.002313967,"threshold_uncertainty_score":0.9997515},"labels":[],"label_agreement":null},{"id":"W2168503278","doi":"10.1080/07357900601063766","title":"A Systematic Review on Drug Interactions in Oncology","year":2006,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Drug; Oncology; Clinical Oncology; Internal medicine; Pharmacology; Medical physics; Cancer","score_opus":0.1370314656954665,"score_gpt":0.47981807028664536,"score_spread":0.3427866045911788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168503278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009285002,0.9901428,4.7393067e-7,0.0012628958,0.0007357862,0.0043921643,0.000035832607,0.000046175373,0.0033745887],"genre_scores_gemma":[0.0000047730664,0.98419017,0.000023835475,0.0029570416,0.000368365,0.006138625,0.00061584235,0.000041202864,0.005660121],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.997897,0.00040479796,0.0009823962,0.00036340716,0.00015751213,0.00019484073],"domain_scores_gemma":[0.9985819,0.0003188457,0.00064184045,0.00028551856,0.000062179344,0.00010974249],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002554113,0.00033360816,0.0026416702,0.00033792463,0.000032719418,0.000008050872,0.00009251917,0.000100491925,0.00024769458],"category_scores_gemma":[0.00009334994,0.00024954288,0.0003266026,0.00055311364,0.00006556145,0.00005209676,0.000016599666,0.0005322777,0.00018160017],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000069908356,0.000100816585,0.000009460615,0.9014798,0.00019165092,0.00003909809,0.000049376667,0.0000011686492,4.8682887e-7,0.000051680203,0.04517108,0.052898407],"study_design_scores_gemma":[0.0002494853,0.000044103985,0.0000029778278,0.50565654,0.0043879943,0.000039586463,0.0000021115138,0.0000031541751,0.0000015252662,0.00001917888,0.4894903,0.0001030219],"about_ca_topic_score_codex":0.00043945218,"about_ca_topic_score_gemma":0.00083542697,"teacher_disagreement_score":0.44431922,"about_ca_system_score_codex":0.0028134228,"about_ca_system_score_gemma":0.0012308785,"threshold_uncertainty_score":0.9999957},"labels":[],"label_agreement":null},{"id":"W2171535564","doi":"10.1080/07357900902849681","title":"Specific Reduction of Fas-Associated Protein with Death Domain (FADD) in Clear Cell Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"FADD; Cancer research; Apoptosis; Clear cell renal cell carcinoma; Death domain; Carcinogenesis; Kidney; Programmed cell death; Medicine; Renal cell carcinoma; Kidney cancer; Biology; Cancer; Pathology; Internal medicine; Caspase; Biochemistry","score_opus":0.012294689211167576,"score_gpt":0.2108930285530206,"score_spread":0.19859833934185303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171535564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977751,0.00052738824,0.00047920077,0.00011576858,0.00005348835,0.00035473937,0.0000073925603,0.000008576599,0.000678388],"genre_scores_gemma":[0.997516,0.000057725585,0.0015793602,0.000032825836,0.00012079591,0.000025086543,0.00018748282,0.000014134392,0.00046658452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917704,0.000060703536,0.000209127,0.0002656194,0.0001366509,0.00015083468],"domain_scores_gemma":[0.99951667,0.000001504638,0.00018099554,0.00016683468,0.000081479,0.000052532414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013600115,0.00011833315,0.00011449207,0.00006377842,0.00004359387,0.000010961415,0.000065779,0.00014764289,0.0000120923],"category_scores_gemma":[0.0000036769175,0.00010932832,0.000033208802,0.00017421917,0.000046022767,0.000009184108,0.000010195644,0.00007883455,0.0000010424781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011903046,0.00004598557,0.001119948,0.000017609358,0.0000029384316,0.0000010937426,0.00017421927,0.00082558097,0.9965544,0.00016833721,0.0001448571,0.00082603504],"study_design_scores_gemma":[0.00086067343,0.00057686126,0.030124072,0.000053565163,0.000008447531,0.0000016290194,0.000072974144,0.00013594731,0.9664151,0.0011631864,0.00044713583,0.00014039563],"about_ca_topic_score_codex":0.00008420307,"about_ca_topic_score_gemma":0.000036315738,"teacher_disagreement_score":0.030139253,"about_ca_system_score_codex":0.00007319433,"about_ca_system_score_gemma":0.00010458214,"threshold_uncertainty_score":0.44582796},"labels":[],"label_agreement":null},{"id":"W2263421483","doi":"10.3109/07357907.2015.1088948","title":"Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Bevacizumab; Glioblastoma; Angiopoietin 2; Medicine; Biomarker; Oncology; Internal medicine; VEGF receptors; Angiopoietin receptor; Chemotherapy; Vascular endothelial growth factor; Cancer research; Chemistry","score_opus":0.029195824880419448,"score_gpt":0.28969299656514963,"score_spread":0.2604971716847302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263421483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839535,0.0018348366,0.00010574228,0.01338578,0.00018015376,0.0002816717,0.00003057261,0.0000068662016,0.00022091015],"genre_scores_gemma":[0.9955887,0.00033551923,0.00017653937,0.0027064085,0.00025100657,0.00034405015,0.000016576843,0.000015503903,0.000565667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989637,0.00010478812,0.00022037813,0.00033499085,0.00015379096,0.00022232522],"domain_scores_gemma":[0.9995032,0.000020665671,0.000066946515,0.00029142524,0.000055527013,0.000062267514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002985498,0.00012541772,0.00010168607,0.0000673562,0.00003767007,0.000015702137,0.0002247385,0.00009392547,0.000022832732],"category_scores_gemma":[0.00008993169,0.00007471063,0.000048746024,0.00029518423,0.00008517072,0.000007830872,0.000043170392,0.000047651898,0.000007791975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000997726,0.00007359255,0.148769,0.00006918089,0.000029598212,0.000008552818,0.0016516071,0.00014353062,0.7220032,0.0013010086,0.100078866,0.02487411],"study_design_scores_gemma":[0.0014616356,0.00038351043,0.12565234,0.00050716015,0.000014371759,0.0000016804944,0.00033966042,0.000014360344,0.51532733,0.0009787328,0.35485294,0.00046624418],"about_ca_topic_score_codex":0.000059930728,"about_ca_topic_score_gemma":0.010454907,"teacher_disagreement_score":0.2547741,"about_ca_system_score_codex":0.000116056835,"about_ca_system_score_gemma":0.00013129269,"threshold_uncertainty_score":0.58340836},"labels":[],"label_agreement":null},{"id":"W2941016857","doi":"10.1080/07357907.2019.1601209","title":"Antitumor and Antiangiogenic Activities of Lenvatinib in Mouse Xenograft Models of Vascular Endothelial Growth Factor-Induced Hypervascular Human Hepatocellular Carcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Lenvatinib; Cancer research; Vascular endothelial growth factor; Hepatocellular carcinoma; Medicine; Angiogenesis; Umbilical vein; Receptor tyrosine kinase; Kinase insert domain receptor; Vascular endothelial growth factor A; Internal medicine; Sorafenib; VEGF receptors; Receptor; Biology; In vitro","score_opus":0.03175972106769036,"score_gpt":0.24783670264573465,"score_spread":0.21607698157804428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941016857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963641,0.0030128192,0.00008384352,0.000014316054,0.00007343614,0.0003182378,0.00008311974,0.000005978705,0.00004414197],"genre_scores_gemma":[0.9990842,0.00047127946,0.00013939274,0.000045701672,0.00007160529,0.000035914294,0.00006274384,0.000029458346,0.00005971995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989462,0.00006879017,0.0003072073,0.00032456583,0.00017800405,0.00017525406],"domain_scores_gemma":[0.9993708,0.000008908068,0.00018575689,0.0002867644,0.00009269385,0.000055080447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012774454,0.00016898771,0.00029377203,0.00010263539,0.000032075903,0.000008572326,0.00012982958,0.00014035651,0.000020213609],"category_scores_gemma":[0.0000127124995,0.00017173427,0.00015371783,0.00012208379,0.00013049215,0.000024208071,0.00005889982,0.00005631568,5.570361e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013881893,0.000014491031,0.36723894,0.00012076933,0.00005052687,3.2541382e-7,0.0001395403,0.00010379621,0.6320634,0.00017598958,0.000007681097,0.00007063814],"study_design_scores_gemma":[0.0007916995,0.00014042588,0.052088004,0.000054431235,0.000028921993,9.795175e-7,0.00009025889,0.0008745957,0.94556385,0.00013925739,0.00004811645,0.0001794401],"about_ca_topic_score_codex":0.0010581738,"about_ca_topic_score_gemma":0.000055927052,"teacher_disagreement_score":0.31515095,"about_ca_system_score_codex":0.000024276116,"about_ca_system_score_gemma":0.00012526714,"threshold_uncertainty_score":0.700312},"labels":[],"label_agreement":null},{"id":"W3002686079","doi":"10.1080/07357907.2020.1720223","title":"Amplification of Chromosome 17 Centromere (CEP17) in Breast Cancer Patients with a Result of HER2 2± by Immunohistochemistry","year":2020,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Essar Steel Algoma (Canada); Sault Area Hospital; NOSM University","funders":"","keywords":"Chromosome 17 (human); Breast cancer; Internal medicine; Biology; Immunohistochemistry; Chromosome; Medicine; Fluorescence in situ hybridization; Cancer; Pathology; Genetics; Gene","score_opus":0.026211123835748643,"score_gpt":0.3091500376235991,"score_spread":0.28293891378785047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002686079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188316,0.0010313526,0.000019083887,0.0055555827,0.000044680753,0.0006190012,0.0006053633,0.000021779919,0.0002200092],"genre_scores_gemma":[0.99837005,0.00022296299,0.00019131151,0.00044332715,0.00008799037,0.00020044929,0.00036091424,0.00003285646,0.00009012006],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99833506,0.000042782027,0.00048291823,0.00034475865,0.0005704624,0.00022401712],"domain_scores_gemma":[0.99868935,0.000025294383,0.00033255905,0.0002750218,0.00046949263,0.00020828359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101935926,0.00015099456,0.00033976737,0.00006508014,0.000025224339,0.0000073620704,0.00015115063,0.0001063284,0.0003325486],"category_scores_gemma":[0.00007994883,0.0001400255,0.000037153237,0.0006704499,0.0003126317,0.000112979935,0.00002907065,0.0002519921,0.000002779632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006379005,0.00010186646,0.44129664,0.0009587744,0.00004766351,9.729423e-7,0.001086702,0.000095176096,0.54396355,0.000011229866,0.009108523,0.0026909867],"study_design_scores_gemma":[0.004128776,0.00029159008,0.6921998,0.0016906213,0.0000697863,0.0000017513927,0.000147427,0.00048303723,0.29969227,0.000025839707,0.0010497177,0.0002193645],"about_ca_topic_score_codex":0.002400914,"about_ca_topic_score_gemma":0.00002608338,"teacher_disagreement_score":0.2509032,"about_ca_system_score_codex":0.000622822,"about_ca_system_score_gemma":0.0008084618,"threshold_uncertainty_score":0.5710074},"labels":[],"label_agreement":null},{"id":"W4286221730","doi":"10.1080/07357907.2022.2104305","title":"Suspension of Oncology Randomized Clinical Trials during the COVID-19 Pandemic: A Cross-Sectional Evaluation of COVID-Related Suspensions","year":2022,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; Odds ratio; Clinical trial; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Randomized controlled trial; Cross-sectional study; Pandemic; Internal medicine; Odds; Cross over; Virology; Logistic regression; Pathology; Medical physics; Disease; Outbreak","score_opus":0.573353065216519,"score_gpt":0.5992513498065951,"score_spread":0.025898284590076148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286221730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97957754,0.00092123315,0.000086613596,0.01489383,0.0011236534,0.0031941887,0.000062268446,0.000052725965,0.00008795468],"genre_scores_gemma":[0.99339235,0.00032567885,0.000046624686,0.00515963,0.00024729926,0.00046186504,0.00017968076,0.000018677849,0.0001681686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98352593,0.011877028,0.002653009,0.00041255733,0.0012958762,0.00023556848],"domain_scores_gemma":[0.984008,0.011501589,0.0023639253,0.00045257344,0.0011429044,0.0005310169],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.060935836,0.00015507305,0.0012063015,0.00025822743,0.00046971743,0.000010144606,0.00013412352,0.00023159766,0.001893765],"category_scores_gemma":[0.078058586,0.000112828086,0.00042026315,0.0005905661,0.0007773055,0.00008350624,0.00010551043,0.00063144055,0.0000027052988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049137738,0.00016125501,0.8954028,0.00035601508,0.00034248506,0.0000058315154,0.0027432821,0.024212366,0.023083987,0.0008547395,0.0013347479,0.002364753],"study_design_scores_gemma":[0.27568892,0.0007848341,0.68182784,0.00010913133,0.0015078676,0.00020857126,0.0006862281,0.020831823,0.0015764725,0.011897254,0.004646985,0.00023408882],"about_ca_topic_score_codex":0.0026866172,"about_ca_topic_score_gemma":0.0006306125,"teacher_disagreement_score":0.22655118,"about_ca_system_score_codex":0.0025558409,"about_ca_system_score_gemma":0.013660864,"threshold_uncertainty_score":0.9990186},"labels":[],"label_agreement":null},{"id":"W4297785721","doi":"10.1080/07357907.2022.2122488","title":"Routine Skin Cancer Screening: Balance between Overdiagnosis and Prevention","year":2022,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Overdiagnosis; Declaration; Medicine; Balance (ability); Cancer; Dermatology; Internal medicine; Computer science; Physical therapy","score_opus":0.04334994949258634,"score_gpt":0.3067660097177656,"score_spread":0.2634160602251792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297785721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909536,0.0009260049,0.000546227,0.0061587086,0.00029919198,0.00052287686,0.000036412865,0.00009068518,0.0004662666],"genre_scores_gemma":[0.9933984,0.00020907205,0.00043805264,0.001464555,0.0003781275,0.000584394,0.000077805635,0.000018390985,0.0034312028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991132,0.00005697335,0.00017795493,0.00025373703,0.00026041872,0.00013768981],"domain_scores_gemma":[0.9995828,0.000023724906,0.00011416626,0.00012934419,0.00003695605,0.00011296253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015926057,0.000098467644,0.00015714607,0.000094809446,0.00020407801,0.000019138748,0.000041233776,0.000029501169,0.0007046226],"category_scores_gemma":[0.000022542474,0.0001068836,0.000040414077,0.00025522552,0.000046797908,0.00006930174,0.000076436605,0.00015485057,0.000002857788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011117551,0.000033355605,0.817339,0.00016070281,0.00018955777,0.000013325234,0.00071265054,0.0009286451,0.0034782426,0.00027053582,0.01961753,0.15714526],"study_design_scores_gemma":[0.0020779157,0.0003941804,0.83894414,0.00018373929,0.0003902271,0.0000342242,0.00038026637,0.0030092523,0.009749507,0.0008395761,0.14371805,0.00027891848],"about_ca_topic_score_codex":0.0006265301,"about_ca_topic_score_gemma":0.00006337998,"teacher_disagreement_score":0.15686634,"about_ca_system_score_codex":0.0002469959,"about_ca_system_score_gemma":0.000071194096,"threshold_uncertainty_score":0.7715123},"labels":[],"label_agreement":null},{"id":"W4399765412","doi":"10.1080/07357907.2024.2363879","title":"Prognostic Effects of Sarcopenia on Patients with Bladder Cancer: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcopenia; Medicine; Meta-analysis; Internal medicine; Bladder cancer; Cochrane Library; Subgroup analysis; Cancer; Oncology; Overall survival","score_opus":0.11492701280648701,"score_gpt":0.40934432836194756,"score_spread":0.2944173155554606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399765412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018553637,0.9904562,0.0000033318202,0.0006451229,0.000071906645,0.008607192,0.0001367828,0.000037115176,0.000023793891],"genre_scores_gemma":[0.000062464314,0.99055624,0.0001125916,0.0023783213,0.000039020622,0.0062423903,0.0002296658,0.00005171858,0.00032755884],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99772376,0.00027644032,0.0009340634,0.00046040493,0.00043423742,0.00017109512],"domain_scores_gemma":[0.99814963,0.0002234541,0.00079841213,0.0003676848,0.0002540004,0.00020679804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002698825,0.00038968123,0.005865521,0.0004090271,0.000042243424,0.000022248483,0.0000757358,0.00012357891,0.00009506832],"category_scores_gemma":[0.00018709211,0.00021499666,0.000593158,0.0012891137,0.000094689145,0.000046871577,0.00002105082,0.00032408777,0.000014763748],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028014758,0.00002318982,0.00006323924,0.9447395,0.053148262,0.0000034566463,0.000039113074,2.7961272e-7,3.1433483e-8,0.00003858786,0.00078681327,0.0011546966],"study_design_scores_gemma":[0.0001419957,0.00009235238,0.000029099194,0.3814406,0.61430466,0.0000016853585,8.035428e-7,0.000003191927,0.0000010210003,0.000011684094,0.003855767,0.00011713437],"about_ca_topic_score_codex":0.000056568064,"about_ca_topic_score_gemma":0.000022624028,"teacher_disagreement_score":0.56329894,"about_ca_system_score_codex":0.00022530255,"about_ca_system_score_gemma":0.00049227197,"threshold_uncertainty_score":0.8767309},"labels":[],"label_agreement":null},{"id":"W4401425810","doi":"10.1080/07357907.2024.2388107","title":"The Landscape and Prognosis of Microsatellite Stable (MSS) Esophageal, Gastro-Esophageal Junction and Gastric Adenocarcinomas with High Tumor Mutation Burden (TMB)","year":2024,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"Mutation; Esophageal adenocarcinoma; Medicine; Esophagogastric junction; Microsatellite; Internal medicine; Microsatellite instability; Cancer research; Esophageal cancer; Gastroenterology; Adenocarcinoma; Cancer; Oncology; Biology; Gene; Genetics; Allele","score_opus":0.013157268460202601,"score_gpt":0.23988201665073752,"score_spread":0.22672474819053492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401425810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809235,0.017000847,0.000100328056,0.0009232436,0.00026481555,0.0006550724,0.000022910182,0.00005883617,0.0000504878],"genre_scores_gemma":[0.9971483,0.00048821303,0.0014243252,0.0000960822,0.00021112931,0.00019219653,0.000047431786,0.00003248973,0.00035982946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883544,0.00005212264,0.0002605296,0.00035098038,0.0002867764,0.000214163],"domain_scores_gemma":[0.99935645,0.00010479607,0.00011378529,0.00013997825,0.00015493875,0.00013005087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021421906,0.00017502934,0.00020418786,0.00012373198,0.00012440294,0.00010250441,0.00004662165,0.00006022334,0.000032436317],"category_scores_gemma":[0.000042728443,0.00012123689,0.000023922548,0.00043382947,0.0003297318,0.00015021463,0.00002635116,0.00017562346,0.0000021480791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093522615,0.000030238603,0.85382277,0.0021368857,0.0003320729,0.000083903156,0.003563299,0.000730336,0.08259489,0.00045041018,0.0020609975,0.05325896],"study_design_scores_gemma":[0.0019133737,0.0021133919,0.8349337,0.00092397316,0.00068675744,0.00037242752,0.0006427645,0.0075246603,0.14842962,0.0009011754,0.0012884788,0.00026969932],"about_ca_topic_score_codex":0.00037103935,"about_ca_topic_score_gemma":0.00005810458,"teacher_disagreement_score":0.06583474,"about_ca_system_score_codex":0.00012580694,"about_ca_system_score_gemma":0.00029847096,"threshold_uncertainty_score":0.49438968},"labels":[],"label_agreement":null},{"id":"W4415356814","doi":"10.1080/07357907.2025.2570382","title":"Examining the Direct and Indirect Effects of Socioeconomic Status on Colorectal Cancer Using Structural Equation Modeling","year":2025,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; National Natural Science Foundation of China","keywords":"Socioeconomic status; Structural equation modeling; Colorectal cancer; Family history; Generalized estimating equation; Cancer","score_opus":0.0607860370334072,"score_gpt":0.3164312972078801,"score_spread":0.2556452601744729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415356814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946853,0.0039536394,0.00005560119,0.00043705007,0.0002968227,0.00033979514,0.000014655918,0.000015500043,0.0002016322],"genre_scores_gemma":[0.9986804,0.00043645003,0.00016863071,0.00048188842,0.00011942464,0.000076351025,0.000014293941,0.000007215036,0.000015355705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944365,0.00003536101,0.00015755898,0.00015469141,0.000091860325,0.00011686675],"domain_scores_gemma":[0.99957764,0.00018071354,0.00008541454,0.00005278308,0.00006768891,0.000035729256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008814731,0.00008706928,0.00017804603,0.000057228604,0.00015963806,0.000011587569,0.000021677562,0.00004326794,0.000007366627],"category_scores_gemma":[0.00008535239,0.00006613615,0.000024037696,0.00009559912,0.0001079796,0.000055325127,0.000019866375,0.000081552884,2.2388235e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046271516,0.000021962223,0.79483783,0.001231803,0.0004817558,0.0000014471855,0.0029648968,0.050193984,0.12950295,0.0014892599,0.00044543782,0.018365957],"study_design_scores_gemma":[0.0020317284,0.00020631716,0.48816577,0.001548735,0.0003692283,0.0000010410512,0.0005442732,0.39503914,0.10803937,0.003835384,0.000048029342,0.00017099213],"about_ca_topic_score_codex":0.0009839146,"about_ca_topic_score_gemma":0.00008333435,"teacher_disagreement_score":0.34484515,"about_ca_system_score_codex":0.00030002146,"about_ca_system_score_gemma":0.00017043449,"threshold_uncertainty_score":0.26969537},"labels":[],"label_agreement":null},{"id":"W4416983134","doi":"10.1080/07357907.2025.2596854","title":"Breast Cancer Susceptibility: Meta-Analysis of Cytochrome P450 2C19 ( <i>CYP2C19</i> ) and Estrogen Receptor-1 ( <i>ESR1</i> ) Genetic Variants","year":2025,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetic variants; Breast cancer; Estrogen; Cytochrome P450; CYP2C19; Estrogen receptor; Genetic variation","score_opus":0.01827648228667883,"score_gpt":0.2783405185910849,"score_spread":0.26006403630440605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416983134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737054,0.023989912,0.00032769935,0.0009345414,0.00011151356,0.00036696,0.00040885556,0.000019144098,0.00013595803],"genre_scores_gemma":[0.99587095,0.0015588854,0.0005672655,0.0010974148,0.00008674017,0.0001940556,0.00021644421,0.000022776398,0.00038548338],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984377,0.00016741766,0.0003945985,0.00058399915,0.00017430173,0.0002420055],"domain_scores_gemma":[0.9989772,0.000026175176,0.00020954276,0.00045118397,0.00019967445,0.00013624363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022004901,0.0002481131,0.0005735323,0.00016488615,0.00009276775,0.000028187074,0.00017322008,0.00026379383,0.000119476776],"category_scores_gemma":[0.000026639762,0.00021735043,0.00037110588,0.0007804639,0.000294674,0.000011793564,0.00009606698,0.00012734937,0.0000018735176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072349736,0.00003313213,0.025623681,0.000086502914,0.0332328,9.0466233e-7,0.000058520924,0.0018376517,0.9352827,0.00015361384,0.0023188777,0.0012992444],"study_design_scores_gemma":[0.0012123812,0.00021026499,0.100160174,0.00005887891,0.12682147,0.000013256102,0.000054789485,0.0014255842,0.7665085,0.00046888398,0.0023842917,0.00068153505],"about_ca_topic_score_codex":0.0006834842,"about_ca_topic_score_gemma":0.00018893206,"teacher_disagreement_score":0.16877423,"about_ca_system_score_codex":0.000049762137,"about_ca_system_score_gemma":0.00029147364,"threshold_uncertainty_score":0.88632935},"labels":[],"label_agreement":null},{"id":"W7117321436","doi":"10.1080/07357907.2025.2599381","title":"Diagnostic Costs of Metastatic and Unknown Primary Cancers in Alberta, Canada, 2017–2021","year":2025,"lang":"en","type":"article","venue":"Cancer Investigation","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; Alberta Health Services","funders":"","keywords":"Stage (stratigraphy); Cancer; Diagnostic test; Cost analysis; Disease; Cost driver; Health care; Baseline (sea); Total cost","score_opus":0.015751605423678344,"score_gpt":0.2763654839179671,"score_spread":0.26061387849428874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117321436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802822,0.009335611,0.000007779038,0.0077126627,0.00029226224,0.0005633198,0.00003797888,0.0000042770876,0.0017639197],"genre_scores_gemma":[0.9948659,0.0020835774,0.00011843707,0.0018954079,0.000031585892,0.00035252748,0.00006429784,0.00000853253,0.0005797177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999168,0.00003186046,0.00026765917,0.00022677495,0.00015850941,0.00014720924],"domain_scores_gemma":[0.999145,0.00042543304,0.00009169975,0.00015774943,0.00007682473,0.00010334187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006971097,0.00012083958,0.00030774533,0.000106359905,0.000028055632,0.0000070693277,0.000035143825,0.00003147063,0.000048597612],"category_scores_gemma":[0.00020010544,0.00011242322,0.000024663532,0.0003196854,0.00010839825,0.000056087032,0.000019279438,0.000080237325,6.1689053e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007977362,0.00007381082,0.9324136,0.00076376344,0.0002591351,0.00004802959,0.0004489517,0.0007083451,0.00056161726,0.003323938,0.023052922,0.03826615],"study_design_scores_gemma":[0.0024057298,0.00007938346,0.97956735,0.0023305411,0.00037012,0.000004424446,0.00007984266,0.00034508356,0.0075340676,0.00043630553,0.0067137466,0.00013340462],"about_ca_topic_score_codex":0.92137104,"about_ca_topic_score_gemma":0.9631937,"teacher_disagreement_score":0.047153782,"about_ca_system_score_codex":0.002216791,"about_ca_system_score_gemma":0.0036314253,"threshold_uncertainty_score":0.64419925},"labels":[],"label_agreement":null}]}